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Nuclear import and export of macromoloecules are essential processes in eukaryotic cells. In 
consequence, different mechanisms of transport developed in the cell, resulting in the 
involvement of different monodirectional or bidirectional transport receptors, which 
recognize specific sequences or regions in their cargos. 
CRM1, the major cellular export receptor can be specifically inhibited by the fungal compound 
leptomycin B (LMB). The inhibitor binds to a sensitive cysteine residue (at position 528) in 
CRM1 resulting in a blockade of the NES recognition site (Kudo et al., 1999; Sun et al., 2013). 
The question arose whether endogenous substances exist, which also have the ability to 
inhibit CRM1 mediated protein export in a similar way. The prostaglandin 15-deoxy-Δ12,14-PGJ2 
(15d-PGJ2) was found to exhibit a partly similar structure like LMB and CRM1 was identified as 
a target of 15d-PGJ2. Mass spectrometry analysis identified 15d-PGJ2 to modify CRM1 at the 
same cysteine residue like LMB. After incubation of cells with 15d-PGJ2, inhibition of CRM1- 
dependent export was observed. Also kinetic measurements of CRM1 mediated protein 
export in living cells showed a clear decrease in export capability of endogenous CRM1 after 
incubation of cells with 15d-PGJ2. Rescue experiments using an LMB insensitive CRM1 with a 
mutation at cysteine 528 also suggested that 15d-PGJ2 modifies CRM1 at the same residue as 
LMB (Hilliard et al., 2010). As a conclusion we present a CRM1 inhibitor which can be 
produced endogenously by cells e.g. during an inflammatory response.  
In contrast to export, import of proteins is largely mediated by import receptors from the 
importin-β superfamily. Import receptors recognize their cargos at specific sequences and 
some of these sequences are already mapped and classified as nuclear localization signals 
(NLS). For some of import receptors, no specific consensus sequence for cargo recognition 
could be identified so far. In consequence, the import pathways of many nuclear proteins still 
remain elusive.  
In this work we gained further insights into the nuclear import of the protein subunit of 
telomerase reverse transcriptase (TERT), which catalyzes the de novo synthesis of telomeric 
chromosome ends. Previous studies identified the cytoplasmic filament nucleoporin Nup358 
to be involved in TERT nuclear import (Hutten, 2007). After depletion of Nup358, TERT 





nuclear localization. In this work, we were able to identify a zinc finger region in Nup358 to 
play a crucial role in TERT nuclear import. Using mutagenesis, we discovered two independent 
NLS sites in the TERT protein, which contribute to nuclear import of TERT. By siRNA mediated 
depletion of major eukaryotic import receptors we were able to identify importin-7 as a 
responsible import receptor of TERT. FLIP experiments, measuring the import kinetics of TERT 
showed a clear decrease in TERT nuclear import upon depletion of importin-7. Rescue 
experiments using a siRNA resistant mutant of importin-7 confirmed these results. 
Together, our findings provide further detailed insights into the nuclear import pathways of 
























1.1 General mechanisms of nucleocytoplasmic transport 
In contrast to prokaryotic cells the eukaryotic cell contains several compartments and its 
genome in the nucleus is isolated from the cytoplasm. The nucleus is surrounded by two lipid 
bilayers, forming the inner and the outer nuclear membrane, which is non-permeable for 
proteins or RNAs. However, several types of RNAs have to leave the nucleus to build a 
ribosome or to be translated into proteins in the cytoplasm. Therefore a mechanism had to 
evolve that selectively permits entrance to the nucleus for a certain subset of proteins and 
also selectively exports proteins and mRNAs to the cytoplasm. To achieve this, the nuclear 
envelope contains pores through which transport of proteins and different RNAs in both 
directions can occur. While small molecules up to 50 kDa can diffuse freely through the pore 
larger molecules utilize specific recognition sequences that can bind a transport receptor to 
enable transport of the cargo through the pore in an energy dependent manner (reviewed by 
Chook et al., 2011; Wente et al., 2010; Pemberton et al., 2005). 
 
 
1.1.1 The nuclear pore complex and its translocation models 
The nuclear pore complex (NPC) is a large cylindrical protein complex that spans the nuclear 
envelope from the outer nuclear membrane to the inner nuclear membrane, creates a 
channel-like structure. The NPC consists of several copies of around 30 different nucleoporins 
(Nups) which form an eight fold rotational symmetry and give the NPC a mass of ~ 125 mDa 
(Akey et al., 1993; reviewed in Alber et al., 2007a; Schooley et al., 2012). As shown in figure I 
the NPC can be divided into several sections. The cytoplasmic one contains seven 
nucleoporins that are located close to the outer nuclear membrane e.g. Nup214 or Nup88 
(reviewed in Hoelz et al., 2011). These Nups form an outer ring of the NPC, which connects 
the cytoplasmic filaments formed by Nup358 (RanBP2) (Walther et al., 2002; Bernad et al., 
2004). The middle part is arranged to give rise to a scaffold that forms a central transport 
channel, the so-called spoke ring (Goldberg et al., 1996). The scaffold forming nucleoporins 





linked to nine coat nucleoporins. Three pore membrane (POM) proteins connected to the 
coat Nups are also linked to pore membrane nucleoporins (POMs) that anchor the NPC into 
the nuclear envelope (Alber et al., 2007b; reviewed in Hoelz et al., 2011). At its nuclear face 
the NPC harbors three Nups forming a basket-like structure ending in a distal ring (reviewed 
in Terry et al., 2009). 
Nucleoporins can also be divided into FG (phenylalanine-glycine)-nucleoporins and non-FG-
nucleoporins. Nearly one third of all Nups belong to the group of FG nucleoporins which 
contain several phenylalanine-glycine repeats (reviewed in Burns et al., 2012). FG-Nups 
facilitate trafficking through the NPC and they are present at the cytoplasmic filaments, 
among the channel Nups where they form the spoke ring as well as in the basket structure 
(Alber et al., 2007b). During passage through the NPC, transport receptors can transiently 
interact with the FGs of the nucleoporins via hydrophobic regions on their surface (Ribbeck et 
al., 2001; reviewed in Pemberton et al., 2005). There are currently several different models in 
the literature describing how transport receptors with their cargos could translocate through 
the pore.  
 
                
 
Figure I: The nuclear pore complex (Hoelz et al., 2011) 
A schematic model of the vertebrate nuclear pore complex with its sub compartments. The pore is constructed 
of several different nucleoporins with different properties which form cytoplasmic filaments, the translocation 
channel and the nuclear basket. The nuclear pore provides a selective barrier between nucleus and cytoplasm, 
permitting transport of only certain proteins. 






The “hydrogel-model” for example suggests that FGs of different nucleoporins form a gel-like 
meshwork within the central channel of the NPC. Transport receptors can interact with the 
FGs through hydrophobic regions on their surface, disrupt the inter FG connections and thus 
translocate through the pore (Ribbeck et al., 2001; Frey et al., 2006; Frey et al., 2007). 
Observations during atomic force microscopy indicates, that FG repeats collapse after binding 
of transport factors. By this interaction, transport factors open up their own channel through 
the FG meshwork and translocate through the pore (Lim et al. 2007a; Lim et al. 2007b; 
reviewed in Wente et al., 2010) 
The “reduction in dimensionality”-model hypothesizes that the inner surface of the transport 
channel is coated by FG repeats. Transport receptors entering the channel can bind to the 
FGs and move by a random walk on the inner surface of the transport channel. They have full 
access and can pass the NPC easily. Molecules that are unable to bind FGs cannot pass the 
tube easily and are excluded when they are too large to pass the FG-free central part of the 
NPC channel (Peters 2005; reviewed in Wente et al., 2010). 
All models mentioned above have in common that solely the interactions of FG repeats with 
transport receptors are responsible for translocation of receptor-cargo complexes through 
the pore. There are hints that several classes of FG repeats exist depending on their charge, 
density and FG repeat motif, hence exhibiting different physical behavior (Krishnan et al., 
2008). Different transport factors then may preferentially bind to only certain FG repeats. In 
consequence, very diverse, functionally independent, and yet specific transport pathways 
through the pore might exist (reviewed in Tran et al., 2006).     
In contrast, the “virtual gate”- model proposes the NPC to function as an energetic barrier 
with non- cohesive FG-nups reaching into the transport channel (Rout et al., 2003). Soluble 
molecules possess a certain defined energy state. Following this model, the NPC requires a 
certain energy state for molecular transition. Smaller molecules may possess this energy and 
can reach this required “transition state” and translocate through the pore. Larger molecules 
are restricted from this strategy because the energy required for their translocation is too 
high. In contrast, transport factors with their cargos bind to the FG repeats, decreasing the 
required energy, and can so reach the transition state. 
Apart from the described single models hybrid models also exist, combining at least two 
models and theories. A very recent hybrid model is the “forest-model”, combining the “virtual 





“forest”-like landscape within the nuclear pore channel enabled by their diverse structure and 
interactivity, and dependant on their ability to collapse or to form longer relaxed stretches. 
Using these different behaviors the authors classify FG-Nups into “shrubs” with only collapsed 
coils and “trees”, bearing an extended structure with coils sitting on it. These “trees” reach 
into the central part of the transport channel, where transport receptors bound to large 
substrates translocate, creating a permeability barrier described by the “hydrogel”-model. In 
contrast, the “shrubs” create a different zone close to the wall of the transport channel where 
small molecules and transport receptors with smaller cargos can translocate. There 




1.1.2 Signal-and receptor-mediated nucleocytoplasmic transport through the pore 
Cargoes are bound by soluble transport receptors through specific sequences and are 
transported in an energy dependent manner. Among eukaryotes transport receptors are 
evolutionary conserved and exhibit a size of 90-145kDa. Around 20 transport receptors are 
known and most of them belong to the importinβ-like family (reviewed by Pemberton et al., 
2005; Fried et al., 2003). Import from the cytoplasm into the nucleus is mediated by several 
importins while export out of the nucleus into the cytoplasm occurs through binding of 
exportins to their cargo. Importins bind their substrates via small recognition sequences, so 
called nuclear localization signals (NLS), within the cargo. Via interaction with components of 
the nuclear pore, this import complex translocates to the nucleus. In the nucleus, the import 
substrate is released by binding of RanGTP to the receptor. The receptor-RanGTP complex is 
later translocated back to the cytoplasm (Jäkel et al., 1998; Izaurralde et al., 1997).  
One of the first and very well characterized import sequences is the classical nuclear 
localization sequence (cNLS) which is composed of the amino acids lysine and arginine 
[K(K/R)X(K/R)] (Conti et al., 2000; Kalderon et al., 1984). It can either occur as a monopartite 
cNLS which comprises one basic region or as a bipartite cNLS which consists of two basic 
regions (Dingwall et al., 1982; Robbins et al., 1991).  A cNLS is recognized by importin-α which 
again is recognized by importin-β. Importin-β binds importin-α at its IBB (Importinβ-binding 
domain) and the complex is then translocated through the pore (Görlich et al., 1996). 





parathyroid hormone-related protein (PTHrP) are importin-β dependent cargos (Moore et al., 
1999; Cingolani et al., 2002). 
Other nuclear localization signals exist that bind to import receptors other than importin-β or 
importin-α. Another well characterized import signal is the glycine rich M9-sequence 
containing a PY-motif which is recognized by transportin directly (Siomi et al., 1997; Nakielny 
et al., 1996). This sequence is defined by the existence of positively charged amino acids 
within the motif with the consensus sequence R/K/HX(2-5)PY (Lee et al., 2006).  
Besides this signals also exist that are recognized by multiple import receptors like the BIB 
(beta-like import receptor binding) domain in rpL23a (Jäkel et al., 1998). The HIV-1 Rev 
protein has also been shown in-vitro to be imported by several import receptors via an 
arginine-rich region (Arnold et al., 2006). 
 
 
        
 
Figure II: The transport cycle (Wente et al., 2010) 
A schematic depiction of the import and export cycle in a vertebrate cell depending on the cofactor Ran. 
RanGTP bound import receptors translocate from the nucleus into the cytoplasm and are freed from Ran 
following the hydrolysis of GTP to GDP. They recognize their substrate in the absence of Ran in the cytoplasm, 
translocate through the pore into the nucleus where the cargo is then released by RanGTP binding to the 
receptor. In contrast to import receptors, binding of substrates to export receptors requires RanGTP. This 
trimeric export complex translocates through the pore into the cytoplasm where the cargo is released after 








Nuclear export is mediated by exportins, which recognize their substrates via a nuclear export 
signal (NES). Among the importin β-like family of nuclear transport receptors, there are eight 
nuclear export receptors known (reviewed in Fried et al., 2003; Weis, 2003). Most of them are 
highly specialized receptors transporting just a few cargos. They also mediate export of 
several endogenous RNAs and viral RNAs (reviewed in Carmody et al., 2009, Wente et al., 
2010). 
The main export receptor in the eukaryotic cell is a very well characterized export factor 
CRM1 (chromosome region maintenance 1) (Stade et al., 1997; Fornerod et al., 1997). CRM1 
recognizes its substrates in the nucleus at a hydrophobic leucine-rich region with the 
consensus sequence (ϕ1 X2-3 ϕ
2 X2-3  ϕ
3 X ϕ4) consisting of hydrophobic amino acids (ϕ) with a 
regular interval of random amino acids (X) (Fornerod et al., 1997a; Kosugi et al., 2008). 
Additionally to the NES the receptor binds a cofactor called RanGTP forming a trimeric 
complex. Formation of this trimer is assisted by Ran-binding protein 3 (RanBP3) that links 
Crm1 to the Ran guanine nucleotide exchange factor (RCC1/ RanGEF) (Fornerod et al., 1997a; 
Fried et al., 2003; Lindsay et al., 2001; Nemergut et al., 2002).  
(see also 1.2.2 for detailed description of CRM1) 
 
 
1.1.3 The cofactor Ran 
The small protein Ran belongs to the Ras family of GTPases and is involved in 
nucleocytoplasmic transport (Bischoff et al., 1991; reviewed in Pemberton et al., 2005; 
Stewart, 2007). Ran exhibits a weak intrinsic GTPase activity, which is enhanced after binding 
to RanGAP (Ran-GTPase activating protein) (Bischoff et al., 1994). Ran can exist in a GTP 
bound state as well as in a GDP bound state (Bischoff et al., 1991). In the cytoplasm only low 
RanGTP levels are detectable, Ran is present predominantly in a GDP bound state. In the 
nucleus, GDP exchanged by the chromatin bound nucleotide exchange factor RCC1 (RanGEF) 
to yield GTP. This asymmetric distribution of GDP and GTP loaded Ran between cytoplasm 
and nucleus contributes to the directionality of transport in the cell (Mattaj et al., 1998; 
Görlich et al., 1999; Bischoff et al., 1991a). This Ran gradient is involved in regulation of 
transport since RanGTP binds to the incoming import complexes and releases the cargo from 
its receptor (Rexach et al., 1995; Görlich et al., 1996a; Floer et al., 1997). RanGTP binding to 





(Jäkel et al., 1998). In contrast to import complexes which bind their cargos in the absence of 
Ran in the cytoplasm, export receptors require RanGTP to bind their cargos. In the nucleus 
the export receptors form trimeric complexes with their cargos and the cofactor RanGTP. 
Following the formation of a trimeric export complex, the complex translocates through the 
pore into the cytoplasm (reviewed in Wente et al., 2010). There, the cargo has to be released 
from the export receptor. In the trimeric complex RanGTP is insensitive towards RanGAP 
mediated nucleotide hydrolysis of RanGTP and therefore additional factors become necessary 
for release of the cargo. The soluble cytoplasmic protein RanBP1 (Ran-binding protein1) and 
also the nucleoporin Nup358 with its four Ran-binding sites contribute to the dissociation of 
trimeric export complexes in the cytoplasm (Bischoff et al., 1997; Matunis et al., 1996). The 
export factor is recycled back to the nucleus to be available for another round of transport. 
RanGDP is also imported back into the nucleus via the nuclear transport factor2 (NTF2) where 





1.2 Transport receptors and their mechanisms 
 
1.2.1 The importin-β-like superfamily 
The importin-β-like superfamily of transport receptors contains the largest number of import 
receptors in the eukaryotic cell. All members of this family contain an N-terminal Ran-binding 
domain and possess a similar overall structure (reviewed in Fried et al., 2003). A very well 
characterized import receptor is importin-β. This import receptor consists of 19 tandemly 
repeated HEAT (Huntington, elongation factor 3, ‘A’ subunit of protein phosphatase 2A and 
TOR1) repeats. One HEAT repeat comprises 2 helices which are connected by a loop 
(reviewed in Pemberton et al., 2005; Cingolani et al., 1999; Cingolani et al., 2002). Among the 
import receptors importin-β shows an exceptional behavior since it can form heterodimers 
with importin-α (Görlich et al., 1995) or importin-7 (Görlich et al., 1997; Jäkel et al., 1999). 






Importin-7 is a Ran-binding protein of 119kDa with few identified cargos for example the 
murine zinc finger protein called EZI, ERK-2, MEK1 and Smad3 (Saijou et al., 2007; 
Chunderland et al., 2008; reviewed in Chook et al., 2011). Other cargos e.g. the ribosomal 
proteins rPL23a, rPS7 and rPL5 are also known substrates of importin-7, but interestingly they 
are also substrates of other transport receptors e.g. importin-5, -9, -α/β and transportin (Jäkel 
et al., 1998).  
Although binding regions for several importin-7 cargos have been mapped, a specific 
recognition motif has not been determined until now. Very often importin-7 cargos are bound 
by the import receptor at various domains and long stretches of 50 amino acids or more are 
involved in binding (see figure III) (Chook et al., 2011). In EZI for example, a region between 
zinc fingers 9-12 could be identified as the essential import region (Saijou et al., 2007). It 
could therefore be that importin-7 recognition motifs are structurally very diverse (Chook et 
al., 2011). In this work we present a new import substrate of importin-7. 
 
 
1.2.2 CRM1 recognizes its cargo via a nuclear export signal (NES) and thereby undergoes 
conformational changes 
CRM1 is a very well-studied export receptor in the mammalian cell forming a trimeric export 
complex consisting of the receptor, RanGTP and a CRM1 specific cargo. CRM1 recognizes 
proteins containing a hydrophobic, mostly leucine-rich NES motif (Fischer et al., 1995; Zhang 
et al., 1998). Very recently a structure of Chaetomium thermophilum CRM1 which possesses 
50% homology towards human CRM1 has been solved in the absence of additional factors 
such as RanGTP or snurportin (Monecke et al., 2013). The export receptor comprises a 
structure often referred to be ring-like and consists of 21 HEAT repeats (Monecke et al., 2013; 
Monecke et al., 2009; Dong et al., 2009). For a long time it remained unclear whether the 
binding of RanGTP causes changes in the CRM1 conformation. As shown by Monecke et al., 
2013, Ran binds to CRM1 and interacts with an acidic loop between heat repeat 9A and 9B. 
This binding causes structural changes within the receptor. Upon binding, the C-terminal heat 
repeat H21 flips towards the N-terminus, interacting with heat repeats H2 to H5, providing 
space in the middle of the CRM1-ring for RanGTP binding (figure III B/D). In contrast to this 
change in conformation the authors showed that empty CRM1 exhibits a more relaxed and 





close to the hydrophobic cleft of CRM1 (figure III A). When CRM1 binds NES substrates e.g. 
snurportin1 (SPN1) or RanBP1 the conformation of the receptor also changes. 
 
                  
 
 
Figure III: Conformational changes in CRM1 after binding of NES-cargos and RanGTP (taken from Monecke et 
al., 2013) 
(A) Free ctCRM1 exhibiting a relaxed conformation with a blocked hydrophobic cleft, indicated by the arrow 
head. (B) CRM1*RanGTP*SPN1 complex (C) CRM1*SPN1 complex (D) CRM1*RanGTP*RanBP1 complex (B-D) 
Upon binding of substrates to the CRM1 molecule, N- and C- termini move closer together, therefore opening 
the hydrophobic cleft and enhancing its availability for export substrates. 
 
N- and C- termini of CRM1 move closer together and opens helices 11A and 12A, making the 
hydrophobic cleft accessible for NES-cargos (figure III C/D) ( Koyama et al., 2010; Monecke et 
al., 2013). 
The hydrophobic cleft in the region of HEAT repeats 11A and 12A, providing the NES binding 
site, locates at the convex surface of CRM1. Although there is no common binding mechanism 
and NES sequences differ among proteins they all bind to this hydrophobic cleft (Güttler et al., 
2010). The binding affinity of most NES-cagos to the cleft is low (Askjaer et al., 1999). The 
CRM1 cargo SPN1 is an exception, it binds to CRM1 even in the absence of RanGTP (figure IV 





Other studies show the involvement of an α-helical C-terminal part of CRM1 in substrate 
binding. After binding of RanGTP to CRM1 the loop of HEAT repeat 9 becomes an ordered β-
hairpin that interacts with HEAT repeats 12-15. As a result, the α-helix and the loop of HEAT 
repeat 9 can contribute to NES-substrate binding (Dong et al., 2009; Fox et al., 2011). 
Besides proteins, CRM1 can also export several RNAs e.g. some mRNAs, uridine-rich small 
nuclear RNAs, viral RNAs and ribosomal RNAs with the help of NES containing adaptor 
proteins (Moy et al., 2002; Gadal et al., 2001; Fisher et al., 1995; reviewed in Rodriguez et al., 
2004). It is known that the 60S pre-ribosomal RNA is exported by CRM1 (Gadal et al., 2001) 
and there are hints of an involvement of CRM1 in intranuclear trafficking of snpRNPs (Pradet-
Balade et al., 2011). 
The complete mechanism of translocation of the trimeric export complex has not yet been 
completely solved. But, it is known that the complex translocates through the pore by 
interacting with the nucleoporins Nup88/Nup214 (Kehlenbach et al., 1999; Hutten et al., 
2006; Roloff et al., 2013). The trimeric complex is then dissociated with the help of Nup358, 
NTX1, RanBP1 and RanGAP1 (Black et al., 2001; Bischoff et al., 1997; Mahajan et al., 1997). 
 
 
1.2.3 Specific inhibition of CRM1 by LeptomycinB 
Leptomycin B (LMB) is an unsaturated fatty acid derived from a fungus (Hamamoto et al., 
1983a; Hamamoto et al., 1983b). It is also known to be a highly specific and potent inhibitor 
of CRM1 mediated protein export. It covalently modifies a sensitive cysteine residue at 
position 528 located in the hydrophobic cleft and thus abolishing docking of export substrates 
to the receptor (Kudo et al., 1999).  
In a very recent study it was shown that not only LMB alone is responsible for attacking the 
cysteine, but furthermore CRM1 itself contributes and enhances binding of LMB to cysteine 
528 by driving a chemical reaction. Following the initial CRM1-LMB interaction the export 
receptor drives lactone hydrolysis, thereby strengthening the modification by LMB. This step 
enhances the inhibitor potency and results in irreversibility of this modification (Sun et al., 
2013). This extraordinary behavior of the CRM1-LMB interaction can also help to explain the 







1.3 The prostaglandin 15-deoxy-Δ12,14-PGJ2 
Prostaglandins are small signaling molecules, involved in inflammatory response, thrombosis, 
gastrointestinal secretion and in apoptosis (Shin et al., 2009; Ho et al., 2008). Prostaglandins 
derive from arachidonic acid, which is released from lipid plasma membranes by 
phospholipase A2. 
Arachidonic acid is then processed by cyclooxygenase1 and -2 to form prostaglandinH2 
(PGH2), a precursor in the synthesis of many other prostaglandins. PGH2 is further processed 
by Hematopoietic-prostaglandinD2 synthase (H-PGDS) and/or the Lipocaline-type PGDS (L-
PGDS) to prostaglandinD2 (PGD2). Hydrolysis of PGD2 forms the prostaglandin J2 -series such 
as 15-deoxy-Δ12,14-PGJ2 (15d-PGJ2) (reviewed in Uchida et al., 2008; Scher et al., 2004).  
Prostaglandin 15d-PGJ2 seems to be unique among the prostaglandins. In contrast to other 
prostaglandins which bind to extracellular receptors and trigger a signal transduction cascade, 
15d-PGJ2 acts mainly intracellular. In addition, 15d-PGJ2 displays anti-inflammatory effects 
(Straus et al., 2001). This can be explained by the action of 15d-PGJ2 as a high-affinity ligand 
for the peroxisome proliferator-activated receptor γ (PPARγ) (Straus et al., 2000). PPARγ 
interacts with inflammation stimulating transcription factors in the nucleus but can be also 
involved in complex formation with transcriptional coactivators and corepressors. It has been 
shown that PPARγ also modulates the activity of kinases involved in pro-inflammatory 
pathways (reviewed in Uchida et al., 2008). The PGJ2 anti-inflammatory effect can be also 
enhanced by its involvement in cellular apoptosis (Shin et al., 2009; Ho et al., 2008).   
PGJ2 and its metabolites e.g. 15d-PGJ2 are structurally characterized by a cyclopentenone ring 
that contains an electrophilic group. The prostaglandin 15d-PGJ2 is also described as an 
electrophile having the ability to covalently modify nucleophiles by a Michael addition via a 
free reactive group, affecting the functionality of its targets (reviewed in Uchida et al., 2008; 
Straus et al., 2000). Another explanation for its anti-inflammatory effect is that 15d-PGJ2 
targets for example IκB kinase. In the inflammatory response IκB kinase is activated and 
phosphorylates IκB at two serines. IκB can then be degraded NF-κB is released and can 
migrate to the nucleus to activate gene expression. After 15d-PGJ2 has targeted IκB kinase it  
inhibits DNA binding of NFκB and transcription of the cyclo-oxygenase 2- gene (COX2), which 
catalyses the synthesis of pro-inflammatory prostaglandins, (Straus et al., 2000; Rossi et al., 





2004). Another target of covalent 15d-PGJ2 modification seems to be the HIV transactivating 
protein Tat, which is inhibited by the modification (Kalantari et al., 2009). 
Due to its modifying behavior towards sensitive cysteine residues it is likely that 15d-PGJ2 has 
many targets within a cell and may therefore strongly influence cell fate. In this work we show 
evidence that 15d-PGJ2 covalently modifies the export receptor CRM1 and inhibits CRM1 





Figure IV: Synthesis way of 15d-PGJ2 (taken from Scher et al., 2004) 
Phospholipase A2 releases arachidonic acids from plasma membranes. Cyclooxygenases-1 and -2 
process arachidonic acids to the precursor prostaglandin H2. Further enzymatic processes and 










1.4 Telomerase reverse transcriptase  
Telomeres are the ends of eukaryotic chromosomes and consist of proteins and TTAGGG DNA 
repeats in humans (Morin et al., 1989). After each round of cell division telomeres shorten, 
due to the inability of the replication machinery to complete duplication, termed the “end 
replication problem”. As a consequence, cells with incomplete replication at their 
chromosome termini would later be unable to divide anymore and die (Harley et al., 1990; 
Hastie et al., 1990; reviewed in Autexier et al., 2006). With the help of telomerase activity, 
cells overcome this problem. Telomerase exhibits enzymatic activity and is a conserved 
enzyme among various species. This ribonucleoprotein is involved in chromosome 
maintenance and telomere elongation.  
Telomerase catalyzes the de novo addition of lost telomeric sequences and therefore helps to 
regenerate telomeres, contributes to cell cycle progression and enhances the life-span of cells 
(Greider et al., 1989; Morin 1989, Blackburn et al. 1989; Counter et al., 1992). The enzyme is 
also involved in ageing, cancer development and diseases like dyskeratosis congenital 
(Mitchell et al., 1999; Harley et al., 1990).  
Human telomerase reverse transcriptase is a ribonucleoprotein that comprises two subunits. 
The 126kDa protein subunit (TERT) binds an RNA component (TR) with a conserved secondary 
structure (reviewed in Lamond 1989; Shippen-Lentz et al., 1990; Bhattacharyya et al., 1994). 
To restore lost telomeric sequences during a cell cycle, TR contains a template sequence 
which is used to sequentially add the telomeric repeats (Shippen-Lentz 1990; Morin 1989). 
Telomerase activity was first discovered in ciliated protozoa e.g. Tetrahymena thermophila 
which posesses 104-107 macronuclear telomeres. Later, telomerase activity was also 
demonstrated in a human HeLa cell lysate (Greider et al., 1985; Morin 1989; Avilion et al., 
1992; reviewed in Autexier et al., 2006). 
 
 
1.4.1 Domains and structure of TERT 
TERT contains several domains which are largely conserved in several species (Figure V). The 
most prominent and best characterized domains are the N-terminal extension domain (NTE) 
and the reverse transcriptase (RT) domain. The NTE consists of several conserved telomerase 
specific motifs which form the telomerase RNA binding domain (TRBD) and are therefore 





affect the rate of template copying during telomere synthesis (reviewed in Wyatt et al., 2010). 
The TEN-domain is also involved in TR binding although it possesses a weak affinity towards 
TR (Jakobs et al., 2006). Furthermore, the TEN-domain exhibits binding affinity towards single 
stranded telomeric DNA and contributes to the enzymatic activity (reviewed in Wyatt et al., 
2010). 
The RT-domain is crucial for the enzymes catalytic activity (Lingner et al., 1997) and contains 
evolutionary conserved RT motifs (Harrington et al., 1997; reviewed in Autexier et al., 2006). 
For tribolium castaneum TERT, it has been shown that the RT domain is separated into the 
“fingers” and “palm” subdomains (Gillis et al., 2008). The IFD (insertion in fingers domain) in 
between helps to organize and stabilize the RT region (Gillis et al., 2008; Nakamura et al., 
1997; Lingner et al., 1997). 
Endogenous TERT localizes to the nucleus. The enzyme is found in the nucleoplasm as well as 
in nucleoli, nucleoplasmic foci and at the telomeres. In contrast, TR is known to accumulate in 
Cajal bodies and to associate with nucleoli. It remains unclear in which cellular compartment 
assembly of TERT and TR finally occurs (Wong et al., 2002; reviewed in Collins 2006).  
Nevertheless it is known that assembly of TERT and TR requires additional factors that link 
both subunits tightly together. For tetrahymena TERT and TR assembly it has been shown that 
the telomerase specific p65 holoenzyme protein, which belongs to the La family, contributes 





Figure V: Human TERT and its domains (taken from Wyatt et al., 2010 and modified) 
Human TERT consists of several conserved domains. The telomerase specific (TS) motif and CP, QFP motifs 
form the TR binding domain (TRBD).The RID1 RNA interaction domain1 lies within the TEN domain. Both RNA 
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1.4.2 Biogenesis of human TERT holoenzyme 
The TR binding H/ACA trimeric protein complex consist of dyskerin, NOP10 and NHP2 and 
forms in the cytoplasm. Additionally, NAF1 is recruited to the complex. In the nucleus NAF-1 
recruits the RNA polymerase II and its specific transcription factors and mediates the co-
transcription loading of the H/ACA complex (Darzacq et al., 2006; reviewed in Hukezalie et al., 











Figure VI: Biogenesis of telomerase (taken from Hukezalie et al., 2013) 
Biogenesis of TR and complexing of it as a TR-RNP is mediated under involvement of H/ACA- proteins. 
The assembly of TERT-TR holoenzyme requires additional proteins and nuclear compartments such 
as Cajal bodies or the nucleolus. 
 
recruitment of the TR-ribonucleoprotein complex at the nucleoli (Darzacq et al., 2006). There, 
a Cajal body localization factor mediates the translocation of the TR-ribonucleoprotein to the 
Cajal bodies (reviewed in Hukezalie et al., 2013). The H/ACA complex is essential for the TR 
stability and essential for biogenesis and assembly of TR with TERT. The H/ACA proteins also 
remain at the TERT/TR ribonucleoprotein complex during its catalytic cycle (Egan et al., 2012). 
Prior to assembly of TERT with TR-RNP, TERT passes the nucleolus, due to its interaction with 
the nucleolar proteins PinX1 and nucleolin (Banik et al., 2004).  
Assembly of the TERT/ TR-RNP complex involves the ATPases pontin and reptin (Venteicher et 
al., 2008) which dissociate from active telomerase again (reviewed in Hukezalie et al., 2013). 
The nucleolar proteins NAT10 and GNL3L assemble with the active holoenzyme, suggesting 
that telomerase travels between nucleolus and Cajal bodies (Fu et al., 2007). Regeneration of 
telomeric DNA ends is believed to be synthesized at the Cajal bodies (reviewed in Hukezalie et 
al., 2013). 
In yeast the telomerase RNA was found to colocalize with telomeres in G1- to S-phase but 
lacking of any one of the telomerase holoenzyme-forming Est proteins leads to TLC1 RNA 
accumulation in the cytoplasm (Gallardo et al., 2008). The authors could show that 
endogenous TLC1 RNA traffics between nucleus and cytoplasm and associates with the Crm1p 





1.4.3 Nucleocytoplasmic transport of human TERT 
Not much is known about transport pathways of TERT and import of telomerase specially 
remaines unclear. However, it was already suggested that human TERT can be exported by 
CRM1 in a Ran dependent manner (Haendeler et al., 2003; Seimiya et al., 2000). It has also 
been shown that exogenously or endogenously triggered oxidative stress can initiate Ran 
dependent nuclear export of TERT, through the nuclear pores and can be inhibited by the 





phosphorylation by the Src kinase family of a tyrosine at position 707 is involved in export of 
TERT triggered by reactive oxygen species (ROS) (Haendeler et al., 2003). Another study 
mentions the involvement of the tyrosine phosphatase Shp2 in nuclear retention of TERT 
(Jakob et al., 2008).   
As already mentioned, overexpressed as well as endogenous human TERT localize to the 
nucleus. It could also be demonstrated that overexpressed GFP-tagged TERT shows a 
subnuclear shuttling in several fibroblasts (Wong et al., 2002). TERT therefore needs to be 
transported into the nucleus and it could be shown that nuclear localization of human TERT is 
enhanced by the interaction of 14-3-3 signaling proteins with the telomerase C-terminus 
(Seimiya et al., 2000). The 14-3-3s blocks a CRM1 binding site, and as a consequence CRM1 
mediated export of telomerase is prevented (Seimiya et al., 2000).  
A very recent publication identified a functional bipartite NLS motif in the N-terminal part of 
TERT which is required for nuclear import of TERT mediated by Akt phosphorylation at serine 
227 (Chung et al., 2012). However the authors did not show an involvement of an import 
receptor in TERT nuclear import. Independently from the study mentioned above, the same 
NLS motif was also discovered in this work and was found to be a functional motif. We are 










2.1) Technical equipment 
Agarose gel documentation    Intas 
Autoclave DX200     Systec 
Bacteria incubator Heraeus function line  Heraeus Instruments    
Bacteria shaker Innova 4430    New Brunswick scientific 
CASY 1       Schärfe System 
Cell culture hood HERAsafe KS   Thermo scientific 
Cell culture incubator HERAcell 150i   Thermo scientific 
Centrifuge 5415D     Eppendorf 
Centrifuge 5415R     Eppendorf 
Developer machine CURIX60    Agfa 
Emulsiflex      GE Healthcare 
Heat blocks      Eppendorf 
HPLC   (Äkta)      GE Healthcare 
LSM 510 meta confocal microscope   Zeiss 
Nanodrop      PeqLab 
SDS Gel eletrophoretsis system   Biometra 
Thermocycler Tprofessional gradient  Biometra 
Thermocycler Primus MWG    Biometra 
Ultracentrifuge     Beckmann Coulter 








Amersham Hyperfilm ECL    GE Healthcare 
Cell culture plastic ware    Sarstedt, Starlab 
Chemiluminescence Immobilon Western  Millipore 
Coverslips (12mm Ø)     Marienfeldt 
GFP Nanotrap      Chromotek 
GST- sepharose     GE Healthcare 
Medix XBU medical x-ray film   FOMA Bohemia 
Microscope slides     Thermo scientific 
Ni-NTA Agarose     Qiagen 
Nitrocellulose PROTRAN    Whatman, GE Healthcare 
Reaction tubes     Sarstedt 
Safe view      Gemtaur 




LSM Image Browser     Zeiss 
LSM Software      Zeiss 
Photoshop CS 5.1     Adobe 











2.4 Kit systems 
NucleoBond Xtra Midi    Macherey-Nagel 
Nucleo Spin Plasmid (Mini)    Macherey-Nagel 
Silica Bead DNA Gel Extraction Kit   Fermentas 
 
 
2.5 Buffers, solutions, media 
Buffers 
Antibody elution buffer    500mM NaCl in 0.2M acetic acid, pH 2.7 
Buffer P1  50 mM Tris-HCl (pH 8), 10 mM EDTA, 100 
μg/ml RNase A 
Buffer P2      200 mM NaOH, 1 % (v/v) SDS 
Buffer P3      3 M KOAc (pH 5.5) 
Carbonate buffer     0.2M carbonate pH 8.9 
Colloidal coomassie     0.02% brilliant blue G250,  
 5% aluminiumsulfate, 10% ethanol,  
  2% orthophosphoric acid 
DNA loading dye 10x  50% (v/v) glycerin, 0.1% (w/v) bromphenol 
blue, 0.1% (w/v)xylencyanole 
 
GFP nanotrap dilution buffer    10mM Tris, 150mM NaCl, 0.5mM EDTA, 
       pH 7.2, 1% BSA 
       freshly supplemented with 2mM DTT,  
       1mM PMSF, 1µg/ml aprotinine, pepstatin,  
       leupeptine, Complete (protease inhibitor) 
 
GFP nanotrap lysis buffer    10mM Tris, 150mM NaCl, 0.5mM EDTA, 
       0.5% NP-40, 1% BSA pH 7.2 
       freshly supplemented with 2mM DTT,  
       1mM PMSF, 1µg/ml aprotinine, pepstatin,  





Immunoprecipitation lysis buffer  20mM Tris, 150mM NaCl, 0.5mm EDTA, 
1% NP-40, 1% BSA pH 7.3 
freshly supplemented with 2mM DTT,  
       1mM PMSF, 1µg/ml aprotinine, pepstatin,  
       leupeptine, complete (protease inhibitor) 
 
Immunoprecipitation washing buffer  20mM Tris, 150mM NaCl, 0.5mm EDTA, 
1% BSA pH 7.3 
freshly supplemented with 2mM DTT,  
       1mM PMSF, 1µg/ml aprotinine, pepstatin,  
       leupeptine, complete (protease inhibitor) 
 
Importinβ lysis buffer     50mM Tris, 2mM MgCl2, 250mM NaCl,  
       10% Glycerol, 4mM β-mercaptoethanol,  
       pH 7.4 
freshly supplemented with 1mM PMSF, 
1µg/ml aprotinine, pepstatin, leupeptine 
 
Importinβ washing buffer    50mM Tris, 2mM MgCl2, 250mM NaCl,  
       10% Glycerol, 4mM β-mercaptoethanol,  
10mM imidazole, pH 7.4 freshly 
supplemented with 1mM PMSF, 1µg/ml 
aprotinine, pepstatin, leupeptine 
 
Laemmli- Buffer 10x     25 mM Tris, 192 mM glycine,  
0.01 % (w/v) SDS  
Optimem      used without any additives 
Paraformaldehyde     3.7% (w/v) paraformaldehyde 
Phoshate buffered saline (PBS)  140 mM NaCl, 2.7 mM KCl, 
 10mM Na2HPO4, 1.5 mM KH2PO4 
(pH 7.5) 
PBS- tween      PBS supplemented with 0.1% (v/v) tween 
Ponceau S   0.5 % (w/v) ponceau S,  
1 % (v/v) acetic acid 
Pull down buffer     50mM Tris, 200mM NaCl, 1% BSA 





SDS-PAGE loading buffer 4x  4 % (w/v) SDS, 125 mM Tris (pH 6.8), 
 10% (v/v) glycerol, 
0.02 % (w/v) bromphenol blue,  
10 % (v/v) β-mercaptoethanol 
TAE- buffer 50x     40 mM Tris acetate (pH 7.7), 1 mM EDTA 
TFB-I-buffer  100 mM RbCl, 15 % (v/v) glycerol, 0.5 mM 
LiCl (pH 5.8) 
TFB-II-buffer  10 mM MOPS (pH 7), 10 mM RbCl, 75 mM 
CaCl2, 15 % (v/v) glycerol 
Transfection buffer 1     250mM CaCl2   
Transfection buffer 2 (HEPES)   50mM HEPES, 250mM NaCl,  
       1,5mM Na2HPO4, pH 6.95   
Western blot transfer buffer     25 mM Tris-HCl, 192 mM glycine,  





Ampicillin       100 mg/ml 
Aprotinin       1 mg/ml 
Chloramphenicol      30 mg/ml 
Dithiothreitol (DTT)      1 M 
Hoechst 33258      10 mg/ml 
Kanamycin      50 mg/ml 
Leupeptin/Pepstatin     1 mg/ml each, in DMSO 
Phenylmethylsulfonyl fluoride (PMSF)  100 mM in 2-propanol 
Penicillin-Streptomycin    Penicillin 10.000 U/ml  










LB 1 % (w/v) bacto-tryptone, 
 0.5 % (w/v) yeast extract, 
1 % (w/v) NaCl (pH 7) 
 
LB agar plates   LB supplemented with 1.5 % (w/v) bacto-
agar 
 
SOC  2 % (w/v) tryptone, 5 % (w/v) yeast 
extract, 50 mM NaCl, 2.5 mM KaCl,  
10 mM MgCl2, 10 mM MgSO4 
 
 
Cell culture media 
CO2 independent medium (Invitrogen) used without additives 
DMEM (high) Invitrogen  DMEM high glucose (4500mg/ml),  





2.6 Enzymes, chemicals and reagents  
 
Enzymes 
Restriction enzymes  Fermentas 
Fast alkaline phosphatase (FastAP) Fermentas 
Phusion polymerase   Fermentas  
Pfu-Ultra polymerase  Agilent 
T4- DNA ligase  Fermentas 
Vent polymerase  NEB 
Trypsin/ EDTA  Invitrogen 









Chemicals and reagents 
All standard chemicals used within this work were obtained from AppliChem (Darmstadt), Carl  
Roth (Karslruhe), Serva (Heidelberg), Sigma-Aldrich (Taufkirchen), or Merck (Darmstadt). 
 
15-deoxy-Δ12,14-prostaglandin J2  Cayman Chemical 
Acrylamid (30 %)   AppliChem  
Advanced protein assay reagent 5x Cytoskeleton Inc. 
Aprotinin   Biomol 
BSA, fraction V   PAA 
Cay 10410  Cayman Chemical 
Dako mounting medium  invitrogen 
Dimethylsulfoxide (DMSO)  AppliChem 
Dithiothreitol (DTT)     AppliChem 
DNA ladder, 1 kb   Fermentas 
dNTPs   Fermentas 
ECL   Milipore 
Ethanol (analytic grade)  Roth 
FCS   Gibco 
Fluorescence mounting medium Dako Cytomation, Linaris 
GDP, GTP   Sigma-Aldrich 
Glutamine (cell culture grade)   Invitrogen 
H2O2   Roth 
Hoechst 33258   Sigma-Aldrich 
IPTG   Fermentas 
Leptomycin B   Sigma-Aldrich 
Leupeptin   Biomol 
Methanol (technical grade)  Roth 
Oligofectamine   Invitrogen 
Oligonucleotides   Sigma-Aldrich 
OptiMEM   Invitrogen 
Pepstatin   Biomol 





Poly-L-lysine   Sigma-Aldrich 
Prostaglandin A  Cayman Chemical 
Prostaglandin E  Cayman Chemical 
Protein ladder PAGE ruler   Fermentas 
siRNA oligonucleotides   Ambion, Santa Cruz, Eurofins 
β-Mercapthoethanol   Roth 








Name Immunogen Species Origin Dilution 
α CRM1  affin., c-terminus H20672 goat Kehlenbach lab WB 1:1000        
IF 1:1000 
α GFP GFP 1-238 rabbit Santa Cruz WB 1:1000 
α HA  clone 16B12 mouse Covance WB 1:1000 
IF 1:1000 
α HIS (penta) HIS-tag mouse Qiagen WB 1:1000 
α importin-α 
(Karyopherin α2) 
Rch-1 254-497 mouse BD Transduction 
Laboratories 
WB 1:1000 
α importin-β importin-β rabbit Kehlenbach lab WB 1:1000 
α importin-7 c-terminal peptide rabbit Görlich lab WB 1:10000 
α importin-7-1 c-terminal peptide 
CLADQRRAAHESKMIEKHG 
rabbit Kehlenbach lab WB 1:500 
α importin-9 clone EP1353Y rabbit Abcam WB 1:1000 
α Myc clone 9E10 mouse Abd Serotec IF 1:1000 
α NUP358  AA 2553-2838 goat Kehlenbach lab WB 1:1000     
IF 1:1000 
α RanBP1 clone35 mouse BD Transduction 
Laboratories 
IF 1:100 







Secondary antibodies for Western blotting were horseradish peroxidase-conjugated (HRP) 
and used in a dilution of 1:10000. The antibodies were obtained either from Dianova or 
Jackson ImmunoResearch Laboratories. 
Secondary antibodies for immunofluorescence were obtained from Molecular Probes and 





SiRNAs were purchased from Ambion, Eurofins or Santa Cruz. The importin-7-1 siRNA from 
Eurofins was selected from a list of predesigned and validated siRNAs. Importin-β and 
importin-9 siRNAs, also obtained from Eurofins, were designed with the online siMAX™ 
Design Tool provided on the webpage. All siRNAs were diluted in nuclease free water to a 
stock concentration of 100µM. 
 
Name siRNA sequence 5’      3’ Target sequence company 
siRNA importin-7 GAUGGAGCCCUGCAUAUGA nct. 1288-1306 
NM_006391 
Ambion 












siRNA non-targeting GAGCUUCAACUAACAGGAATT Scrambled 
sequence 
Ambion 
siRNA NUP358-1 CACAGACAAAGCCGUUGAAUU Nct. 351-369 
NM_006267 
Ambion 









Oligonucleotides used in this work were ordered at Sigma-Aldrich and used at a working 





Oligonucleotides used for mutagenesis 
Name Sequence 5’        3’ 
Mutate Xen IPO7 Ha rev TCATCTGTAGAGCGCCGTCTTT 
Mutate Xen IPO7 Ha for AAAGACGGCGCTCTACAGATGA 
TERT K236A R237A only for AGTCTGCCGTTGCCCGCGGCGCCCAGGCGT 
TERT K236A R237A only rev ACGCCTGGGCGCCGCGGGCAACGGCAGACT 
TERT K649A R650A for TTCCGCAGAGAAGCGGCGGCCGAGCGT 
TERT K649A R650A rev ACGCTCGGCCGCCGCTTCTCTGCGGAA 
 
 
Oligonucleotides used for cloning 
Name Sequence 5’       3’ 
Ran for pEF-HA EcoRI ACGAATTCATGGCTGCGCAGG 
Ran rev pEF-HA SpeI TTACTAGTTCACAGGTCATCATC 
TERT NT for HindIII TTTTAAGCTTCATGCCGCGCGCTCC 
TERT NT 300 rev BamHI TTTTGGATCCTCAGCCCACGGATGG 
TERT NT 150 rev BamHI TTTTGGATCCTCAAACCAGCACGTCG 
TERT NT 301 for HindIII TTTTAAGCTTCCGCCAGCACCACG 




Oligonucleotides used for sequencing 
Sequencing was performed by GATC sequencing service. The DNA samples were diluted to a 
concentration of 100ng/µl and a sample of 20µl was sent for sequencing. Required customer 
primers were diluted to a concentration of 10pmol/µl and were also sent as a 20µl sample. 
 
Name Sequence 5’         3’ 
EF FOR (pEF-Ha) GCCATCTATTGCTTACATTTGCTTCTGACACAACTG 
GFP 3' MCS CCACAACTAGAATGCAGTGAAAA 









TERT 605 EcoR1 F_pGEX KG TTTGAATTCAAGAGGTCAGGCAGCATCGG 
TERT 606-623 seq.Primer CTCGGAACCATAGCGTCAG 
TERT 707 for EcoR1 pmal TTTTGAATTCTACTTTGTCAAGGTGGATGTG 
TERT 927 for EcoR1 pmal TTTTGAATTCCTATTCCCCTGGTGCGG 





2.10 Vectors and plasmids 
All vectors used in this work were available in the lab. 
Name Tag Expression Source 
dGFP-C2 2x EGFP mammalian Based on Clontech pEGFP-C2 
containing additional EGFP 
Dr. Saskia Hutten 
pEF-Ha 2x Ha (N-terminal) mammalian Dr. O. T. Fackler 
(Gasteier et al., 2003) 
pEGFP-C2 EGFP mammalian Clontech 





Tags are always located as shown in the plasmid construct. 
# Name Tag Expression Source 
503 GFP-TF II A alpha  GFP mammalian Dr. Jörg Kahle 
514 NC2ß-RFP RFP mammalian Dr. Jörg Kahle 





545 pCDNA3.1 TERT-HA HA mammalian Dr. Sarah Wälde 
628 pcDNA3.1(+)-Crm1-HA-C528S 
h.s. 
HA mammalian Dr. Stephanie Roloff 
495 pEF-HA importin-7 HA mammalian Wälde et al., 2011 
454 pEF-HA-importin-β 2x HA mammalian Hutten et al.,2008 
795 pEF-HA-Nup358 aa 1-1810 2x HA mammalian Wälde et al. 2011 
794 pEF-HA-Nup358 aa 1-2148 2x HA mammalian Wälde et al 2011 
801 pEF-HA-Nup358 aa 806-1306 2x HA mammalian Wälde et al. 2011 
455 pEF-HA-transportin 2x HA mammalian Christiane Spillner 
(Hutten et al., 2008) 
487 pGFP-NES(Rev) GFP mammalian Christiane Spillner 
1126 pME18S myc-EZI (mouse) myc mammalian Tohru Itoh (Saijou 
et al., 2007) 
623 Rev 68-90-GFP2-M9core 2x GFP mammalian Dr. Saskia Hutten 
(Hutten et al., 
2008/2009) 
504 Rev(68-90)-GFP2-cNLS 2x GFP mammalian Hutten et al., 2008, 




Generated plasmids within this work 
Plasmid inserts were amplified by PCR reaction, digested with the indicated enzymes and 
ligated in the respective vector. Tags are located at the respective termini as indicated in the 
plasmid name. 
# Name Insert Vector Species Primer 
833 TERT-GFP TERT pEGFP-N1 human Cloned via HindIII and 





pEF-HA Xenopus Template vector: pEF-Ha 
importin-7 xen 
Mutate Xen IPO7 Ha rev 
Mutate Xen IPO7 Ha for 




pEGFP-N1 human TERT K236A R237A only 
for 












pEGFP-N1 human TERT K649A R650A for 
TERT K649A R650A rev 
1132 GFP TERT 1-150 TERT 1-150 pEGFP-C2 human TERT NT for HindIII 
TERT NT 150 rev BamHI 
1133 GFP TERT 1-300 TERT 1-300 pEGFP-C2 human TERT NT for HindIII 
TERT NT 300 rev BamHI 
1134 GFP TERT 301-600 TERT 301-600 pEGFP-C2 human TERT NT 301 for HindIII 
TERT NT 600 rev BamHI 
1135 dGFP TERT 1-150 TERT 1-150 2xGFP human TERT NT for HindIII 
TERT NT 150 rev BamHI 
1136 dGFP TERT 1-300 TERT 1-300 2xGFP human TERT NT for HindIII 
TERT NT 300 rev BamHI 
1137 dGFP TERT 301-
600 
TERT 301-600 2xGFP human TERT NT 301 for HindIII 






The proteins listed below belong to the common lab stock. 
Protein Source  
His-importin-7 Kehlenbach lab, (Wohlwend et al., 2007) 
GST NUP 358 aa806-1000 Kehlenbach lab, (Annegret Nath) 
GST NUP 358 aa806-1133 Kehlenbach lab, (Annegret Nath) 
GST NUP 358 aa806-1170 Kehlenbach lab, (Annegret Nath) 
GST NUP 358 aa806-1306 Kehlenbach lab, (Annegret Nath) 
GST NUP 358 aa2011-2445 Kehlenbach lab, (Annegret Nath) 










2.12 Cell lines 
Mammalian cell lines 
HeLap4 This cell line is an adherent immortal human cervix carcinoma cell line and 
stably expresses human CCR-5 and CD4 (Charneau et al., 1994). It was used as 
a standard cell line for immunofluorescence, because it is easy to transfect. 
NIH AIDS Research and Reference Reagent Program, catalog number 3580 
 
293T HEK 293T HEK derived from the adherent and immortal embryonic kidney line HEK 
293. This line is useful for protein expression by supporting the replication of 
plasmids with the Epstein-Barr virus oriP or SV40 origin of replication. 





This strain was used for DNA preparation and cloning. For transformation it was provided 
chemically competent. The genotype of the strain is: F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 
recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
 
 
BL21 (DE3) codon+ 
The BL (DE3) codon+ strain was used for protein induction and preparation. Protein 
expression was induced by addition of IPTG (0.15-1mM) which induced the expression of T7 
polymerase. The genotype of the strain is: E. coli B F– ompT hsdS(rB 
– mB 
–) dcm+ Tetr gal λ








3.1 Prokaryotic cells 
 
Cultivation of E.coli strains 
E.coli strains were grown large scale in conical flasks containing LB-medium, or as mini 
cultures in falcon tubes. Colonies were grown on LB-agar plates. Cultures were incubated at 
37°C and liquid cultures with shaking at 150-170 rpm. For plasmid selection the 
corresponding antibiotics were added as followed: ampicillin 100 μg/ ml, kanamycin 60 μg/ 
ml, chloramphenicol 30 μg/ ml.  
 
 
Preparation of chemical competent bacteria 
Under sterile conditions, E.coli cells were spread onto an LB-agar plate without antibiotics and 
incubated overnight at 37°C. A single colony was picked and inoculated in 200ml of LB-
medium without antibiotics. The culture was grown at 37°C with shaking till it reached an 
OD600 of 0.5. The culture was incubated on ice for 10 minutes and then harvested by 
centrifugation at 5.000 g for 5 min at 4°C. The pelleted cells were resuspended in 200ml of 
ice-cold sterile TFB-I-buffer and further incubated on ice for 2 hours. Cells were again pelleted 
at 5000 g for 5 min at 4°C and carefully resuspended in 8 ml of ice-cold sterile TFB-II-buffer. 
Resuspended competent bacteria were aliquoted in 100µl, snap frozen in liquid nitrogen and 











3.2) Molecular biology techniques 
 
3.2.1 Transformation of plasmid- DNA into E.coli DH5α 
For plasmid transformation, chemically competent cells were used. Cells were defrosted on 
ice, mixed with the plasmid DNA then incubated on ice for a further 30 minutes. Following 
this incubation step, cells were heat shocked at 42°C for 90 seconds and then chilled on ice 
for one minute. During the heat shock DNA is brought into the cells. Cells were recovered in 
SOC medium without antibiotics for 30-45 minutes. Subsequently cells were plated on LB-agar 




3.2.2 Isolation of plasmid-DNA 
Plasmid DNA was extracted from bacteria in different amounts and quality. For isolation, one 
single colony was picked from a plate and inoculated in LB-media. Cells were incubated at 
37°C until they reached stationary phase and were then preparated as follows. 
 
 
Mini-prep (Birnboim et al., 1979) 
Colonies were grown in 6ml of LB-Media overnight and harvested by centrifugation. Cells 
were resuspended in 200µl P1 buffer containing RNase. Subsequently, 200µl of alkaline lysis 
buffer P2 was added to lyse the cells for 3-5 minutes. To stop the reaction, 200µl of 
neutralization buffer P3 was added to the lysate. Precipitated proteins were pelleted by 
centrifugation at 16 000 g for 10 min. The supernatant was transferred into a fresh tube and 
plasmid DNA was precipitated by adding 400µl 2-propanol. After centrifugation for 30 
minutes at 16 000 g, the DNA pellet was washed with 70% ethanol twice, dried and disolved 










Midi and Mini prep with kit 
Plasmid preparation in large scale was performed according to the protocol of the Nucleo 
Bond Xtra Midi kit provided by Macherey-Nagel. Also Mini-preps were performed using the 
Nucleo spin plasmid kit from Macherey-Nagel according to the manufacturer protocol. The 
concentration and purity of the obtained DNA was monitored by measurement with a 
Nanodrop and was then adjusted to 1µg/µl. 
 
 
3.2.3 Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) is a technique used to amplify defined regions of a DNA 
molecule. For this purpose, primers, small oligonucleotides of a length of <20 nucleotides, 
which are complementary to known sequences of the DNA were used to define the region to 
be amplified. Primers can exhibit an overhang at their 5’ ends that does not hybridize with the 
DNA to provide sequences for later endonuclease restriction. For a complete PCR reaction 
also dNTPs, a thermally stable DNA polymerase and a template DNA (100ng) are needed. In 
this work, proof-reading polymerases, e.g. the Phusion polymerase (Fermentas) and the Pfu-
Ultra polymerase (Agilent) were used. PCR reactions were carried out in a volume of 50µl with 
a primer concentration of 200nM and a dNTP concentration of 200µM. To the reaction 0.5-
1U of the polymerase was added. The polymerase buffer was diluted according to the 
manufacturers manual. The PCR reaction was run in several consecutive steps, beginning with 
a denaturation step of 95°C and followed by the annealing phase of the primers to the single 
strand DNA. The annealing temperature was usually determined analog to the G/C content of 
the annealing primer part. The elongation phase was then carried out by the polymerase at 
72°C. The primers were elongated using the existing DNA as a template. A typical PCR 
protocol is shown: 
 
   5 min 95°C initial denaturation 
   1 min 95°C denaturation 
   30 s Tm primer annealing 
   1min/ kb 72°C elongation 







3.2.4 Site-directed mutagenesis 
Mutations were introduced in a gene by site-directed mutagenesis. Complementary primers 
carrying up to 4 nucleotide exchanges were designed and applied in a PCR reaction to 
introduce the mutations into the gene. For this kind of PCR reaction only the Pfu-Utra 
polymerase was used. The reaction volume was set to 50µl and contained 200nm of each 
primer, 250µM dNTPs, 100ng template DNA, 2U polymerase, 10x Pfu-Ultra buffer and 3% 
DMSO to lower the annealing temperature and to facilitate wobble-pairing of bases. The 
annealing temperature was applied in a gradient from 55°C to 80°C. For every mutagenesis, 
10 reactions were pipetted. Nine reactions were subjected to thermocycling while one was 
incubated at room temperature representing the negative control to test the efficiency of the 
following DpnI digestion. After the PCR reaction 1U of the restriction enzyme DpnI and its 
corresponding buffer were added to every sample and incubated for one hour at 37°C. DpnI 
digested the methylated template DNA and left the newly synthesized unmethylated DNA 
intact. Each reaction was transformed into competent E.coli DH5α. Clones were preparated 
and sent for sequencing to identify clones positive for the mutations. A standard PCR protocol 
for mutagenesis is shown below: 
 
    5min 95°C initial denaturation 
    1min 95°C denaturation 
    30s 55°C-80°C primer annealing 
    1min/ kb 72°C elongation 




3.2.5 Agarose-gel electrophoresis  
In this work, gels with an agarose concentration of 1% were used. Agarose-gel electrophoresis 
was used to purify digested DNA. To visualize DNA 5µl of the fluorescent DNA intercalating 
dye Safe View was added to 100ml gel and DNA bands were detectable under UV-light. To 
load DNA into the pockets of a gel it was previously mixed with the appropriate amount of 
10x DNA loading dye. 6µl of a DNA ladder was run in parallel as a marker. The gel was run 






Isolation of DNA bands from agarose gels 
After separation, DNA bands were cut out and were purified with the Silica Bead DNA Gel 





3.2.6 Restriction of DNA fragments 
DNA can exhibit specific sequences that are recognized, bound and cut by prokaryotic 
restriction enzymes. These enzymes bind to a recognition motif and cut the double-strand 
DNA between 2 defined bases.  This is used to create specific overhangs to clone inserts into 
the multiple cloning site of the vector. Digestion of DNA was carried out in a volume of either 
30µl or 50µl using the recommended buffer for the enzymes used. Enzymes were used at a 
concentration of 1-2U per reaction depending on their activity in the buffer system. For the 
purpose of cloning 2-6µg of DNA was used in the digestion reaction. In contrast, analytical 
digestion was carried out using 0.5-1µg of DNA. Digestion was performed at 37°C for 2 hours. 
The DNA fragments were subsequently purified by agarose gel-electrophorese. All restriction 
enzymes used in this work were obtained from Fermentas. 
 
 
Dephosphorylation of vectors 
In the process of cloning, vectors were dephosphorylated to prevent religation of  linearized 
vectors. Dephosphorylation removes phosphates from the 5’ end of DNA molecules and 
supports ligation of the insert. Dephosphorylation was performed after agarose gel-
electrophoresis which follows a restriction digestion with the Fast-AP from Fermentas and its 
respective buffer. The reaction was carried out at 37°C for 15 minutes followed by a thermal 
inactivation at 75°C for 20 minutes. 
 
 
3.2.7 Ligation of DNA  
DNA ligases catalyze the joining of double strand DNA molecules by creating an ester bond 





Fermentas was used. The reaction was set up in 50µl containing the T4 DNA ligase specific 
buffer, the DNA fragments to be ligated and 2,5U of the enzyme. Ligation was either carried 
out at room temperature for 2 hours or overnight at 8°C. The whole reaction was 
transformed into competent E.coli DH5α. 
 
 
3.2.8 Sequencing of DNA 
Probes were sent for sequencing to GATC in Konstanz. DNA concentration was adjusted to 30-
100ng/ µl in a volume of 20µl. Standard primers were provided by GATC. When using a 
specific customer primer they were also sent in a volume of 20µl with a concentration of 





3.3) Biochemical techniques 
 
3.3.1) Detection of proteins and separation 
 
SDS-Page 
The SDS-PAGE of Laemmli describes a technique to separate proteins from each other in high 
resolution via a 2-layer gel system consisting of a stacking gel and a resolving gel (Laemmli 
1970). The proteins are separated in the gel according to their mass in an electric field under 
denaturing and reducing conditions in a buffer system. The resolution and separation of 
protein bands is determined by the pore size of the gel and is dependant on the 
concentration of acrylamide used. In this work, gels of an acrylamide concentration from 8% - 
12% were used. 
Samples were combined with SDS-PAGE loading buffer (final concentration 1x) and heated at 
95°C for 5min. In addition to the samples a protein ladder was loaded onto the gel to later 
determine the molecular weight of the separated proteins. The gels were run in 1x Laemmli 






Via unspecific binding of the dye coomassie brilliant blue G-250 to cationic amino acids, 
proteins can be detected directly in a gel. The method used in this work was a colloidal 
staining and did not require any previous fixation protocol (Dyballa et al 2009 based on Kang 
et al 2002). The solution was prepared 24h prior to use in the following order:  
After the aluminiumsulfate was dissolved in deionized water, 10% ethanol was added and the 
whole solution was homogenized. Next, coomassie G-250 and phosphoric acid were added 
under stirring. Finally the solution was made up to the desired volume with deionized water 
and stirred.  
After running, gels were washed in deionized water with agitation for 2 x 10 minutes to 
reduce background to a minimal level. After washing, gels were placed into the staining 
solution with agitation for at least 3 hours or overnight. Minimal excess of dye was removed 




3.3.2) Protein transfer via Western blot and immunological detection of proteins 
Western blot 
Western blotting was performed under wet conditions to transfer proteins following SDS-
PAGE onto a nitrocellulose membrane in order to detect them with antibodies. For this 
pupose a nitrocellulose membrane and several sheets of whatman paper were equilibrated in 
transfer buffer. The gel and the membrane were then layered with the whatman-paper in a 
blotting cassette. The cassette has to be placed into the blotting tank with the membrane 
facing the positive electrode. Finally, the tank was filled with transfer buffer. Blotting was 




To detect marker bands of an unstained ladder and to confirm equal blotting on a membrane, 
a Ponceau-S stain was applied directly after blotting under slight agitation for 1-2 minutes. 






Immunological detection of proteins on a western blot 
After being transferred onto a membrane, proteins can be visualized via antibody binding and 
a following chemiluminescent reaction. 
First, unspecific binding epitopes on the membrane are blocked with 5% (w/v) milk in PBST for 
30-45 min at room temperature. To detect the proteins of interest specific primary antibody 
were applied in an appropriate dilution in milk and incubated either over night at 4° or for 1-2 
hours at room temperature with slight agitation. Excess of antibody was eliminated by 
washing for 3-5 times with PBST for 5 min each. The HRP (horseradish-peroxidase) coupled 
secondary antibody was used to detect the primary antibody. The secondary antibody was 
also diluted in milk and used at a dilution of 1:10000 and was incubated with agitation for 45 
minutes at room temperature. The blot was again washed 5 times with PBST for 5 minutes 
each. Subsequently, protein bands were visualized by application of a chemiluminescent 
substrate (ECL kit from Millipore), followed by exposure of a light sensitive film and 
development in an automated development machine (AGFA Curix 60). 
In certain cases a membrane was reused for immunological detection, signals were then 
quenched by drying the membrane and leaving it for 2 days at room temperature. Following 
quenching, the membrane was incubated with 1% acetic acid for 15 minutes and blocked in 
5% milk again. 
 
 
3.3.3 Expression and purification of recombinant proteins (named below) 
One day prior to expression, the corresponding plasmid was transformed into BL21 DE3 
codon+ cells. The transformed cells were incubated on LB-agar containing chloramphenicol 
and the selection antibiotic appropriate for the plasmid used. All colonies were inoculated in 
LB medium, supplimented with appropriate antibiotics. The culture was grown at 37°C with 
shaking to a cell density of OD600 0.6-0.8 and induced with IPTG for protein expression. The 
culture was further incubated at 16°C- 20°C over night. 
Cells were harvested by centrifugation and resuspended in the respective lysis buffer 
depending on the protein to be purified. For complete cell lysis, the resuspended culture was 
treated in an emulsiflex 3-6 times, there cells break according to high pressure applied. The 





components. The supernatant was incubated with beads for 2-3 hours at 4°C. Following three 
washing steps, the recombinantly expressed protein was eluted from the beads and 
concentrated in a SpinX-UF concentrator previously blocked with 1% BSA. The protein was 
aliquoted and its purity and concentration was checked on a coomassie gel. 
 
 
Importin7, NUP358 fragments, RanQ69L 
The proteins His-importin-7, GST NUP 358 aa806-1000, GST NUP 358 aa806-1133, GST NUP 
358 aa806-1170, GST NUP 358 aa806-1306, GST NUP 358 aa2011-2445 and Ran Q69L have 




Loading of RanQ69L with GTP (Nachury et al., 1999, modified) 
Equal volumes of 5mM GTP and 5µg RanQ69L were incubated together in presence of 30mM 
EDTA for 20 minutes at room temperature in a volume of 30µl. 15mM MgCl2 was then added 




3.3.4 Affinity purification of antibodies 
In this work, a rabbit α importin-7 antibody was raised and purified. The antibody was raised 
using a peptide from the C-terminal region of importin-7, specifically aa 998-1015 with an 
additional cysteine residue at its n-terminus (CLADQRRAAHESKMIEKHG). The antibody was 
raised in rabbits and the complete immunization of 2 rabbits and the collection and 
processing of the blood was done by Proteintech group.  
For the affinity purification of the importin-7 antibody 1mg of full length importin-7 protein 
was coupled to the CnBr beads. Firstly, 0.4g of CnBr beads were rehydrated in 1mM HCl for 
10 minutes and then equilibrated with 0.2M carbonate buffer pH 8.9. In 0.2M carbonate 
buffer the protein was added to the beads and was then incubated with rotation at 4°C 
overnight. Beads were then washed twice with carbonate buffer for five minutes with 





to saturate free binding sites. After incubation, beads were washed again with carbonate 
buffer as described above, followed by equilibration with 500mM NaCl in PBS. Beads were 
then incubated with 15ml of the relevant serum overnight at 4°C. Subsequently, beads were 
collected carefully and all serum removed by washing twice for five minutes with 500mM 
NaCl/PBS in 50ml volume. Beads were then packed into a column and washed until no protein 
could be detected in the flow-through. Protein detection and later antibody detection from 
flow- through was carried out with Advanced protein reagent (Cytoskeleton Inc.). Purified 
antibodies were eluted with antibody elution buffer under low pH conditions in 500µl 
aliquots. Fractions were neutralized immediately after elution with 100µl Tris-base. After 
elution, fractions were analyzed on nitrocellulose- membrane with a Ponceau-S stain and 
antibody containing fractions were pooled and concentrated. Antibody validation was carried 





Immunoprecipitation was used as a technique to isolate proteins and their interacting factors 
from a whole cell lysate. Sepharose was equilibrated shortly and then blocked with 
immunoprecipitation washing buffer containing 1% BSA for 1.5 hours at 4°C. 
In this work a specific antibody against the target protein was coupled to sepharose by 
incubation. Cells were lysed with immunoprecipitation lysis buffer on ice for 30 min. Cellular 
debris was then removed by centrifugation at 16.000 g for 10 min. Next, the supernatant was 
collected and incubated on the sepharose for 1-2 hours at 4°C. Beads were washed three 
times with immunoprecipitation washing buffer and boiled in SDS-PAGE loading buffer. 
 
 
GFP- Immunoprecipitation using GFP- nanotrap 
A GFP immunoprecipation kit was used to immunoprecipitate GFP tagged proteins. 293T HEK 
cells in 10cm cell culture plates were used for expression. Cells were transfected with the 
relevant plasmid coding for a GFP-fusion protein and incubated for 24-48h. For harvesting, 
cells were trypsinized, pelleted, washed with PBS and pelleted again. For cell lysis, 200µl of 





inhibitors, 1% BSA and DNaseI. Cells were lysed for 30 minutes on ice with pipetting every five 
minutes. A small sample was taken as input control. Following lysis the lysate was centrifuged 
at 16. 000 g for 10 minutes to pellet insoluble components. The supernatant was diluted with 
2.5 volumes of GFP dilution buffer, yielding a tolerable NP-40 concentration of 0.2%. For each 
immunoprecipitation 8µl of GFP-beads were equilibrated in GFP dilution buffer and blocked 
with 1% BSA for 1 hour at 4°C.  The supernatant was then incubated with the beads for 2.5 
hours at 4°C. After incubation, the beads were washed three times with GFP dilution buffer 
without BSA and spun down. Beads were resuspended in 20µl 2x SDS-PAGE loading buffer 
and heated to 95°C for 5 minutes. The samples could now be stored at -20°C or directly 
analyzed on SDS-PAGE. 
 
 
Immunoprecipitation using protein G- sepharose 
Immunoprecipitations are performed from 3-5 10cm plates per experiment using 2µl of goat 
α NUP358 antibody per plate. The antibody was coupled over night to equilibrated protein G 
sepharose, previously blocked with 1% BSA, with rotation at 4°C. After coupling, excess of 
antibody was washed off with immunoprecipitation washing buffer. Per 10cm plate, 5µl of 
sepharose was used. Cells were lysed with 200µl immunoprecipitation lysis buffer per 10cm 
plate on ice for 30 minutes with pipetting every 5 minutes. A small sample referred to as input 
was taken from the lysate and boiled in 2x SDS-PAGE loading buffer for 5 minutes. 
Subsequent to lysis, the lysate was centrifuged at 16.000 g to pellet insoluble components. 
The supernatant was then incubated with the beads for 3 hours at 4°C with rotation. Beads 
were washed with washing buffer without BSA to eliminate unbound proteins. Finally, beads 
were resuspended in 20µl 2x SDS-PAGE loading buffer and heated to 95°C for 5 minutes. The 




3.3.6 In vitro binding assays with GST- and His- tagged proteins (pull down) 
In vitro binding assays using recombinant proteins were performed to demonstrate direct 
interactions between proposed binding partners. In this work, all in vitro binding assays were 





pull down buffer and subsequently blocked with 1% BSA for 1 hour at 4°C with rotation. 5µg 
of a GST- tagged protein was coupled to 10µl of sepharose for 2 hours under rotation. Excess 
of protein was removed in three washing steps with pull down buffer. 5µg of a His- tagged 
binding partner was added and incubated for 1 hour. When indicated, reactions also 
contained 2.5µg of GTP-loaded RanQ69L. Unbound protein was removed by performing three 
washing steps with pull-down buffer. The last washing step was performed without BSA. 
Samples were then resuspended in 2x SDS-PAGE sample buffer and heated for 5 minutes at 
95°C. They were now analyzed on an SDS-PAGE or stored at -20°C. Analysis of the in vitro 






3.4 Cell biological techniques 
 
3.4.1 Cultivation and passaging of adherent cells  
HeLa P4 and HEK 293T cells were grown adherently in Dulbecco’s modified Eagle medium 
(DMEM) supplemented with 10% (v/v) fetal calf serum (FCS) and 2mM glutamine. Both cell 
types were kept without antibiotics permanently. Cells were incubated in a humidified 
HERAcell 150i incubator at 37°C with 5% CO2 atmosphere. 
Cells were passaged by transferring 1/10 of the cells to a new plate every 3-4 days or when 
they reached confluency. Cells were washed with sterile PBS and detached from the culture 
plate by applying prewarmed trypsin/ EDTA. Subsequently cells were diluted in fresh medium 




3.4.2 Coating cover slides with Poly-L-lysine 
To facilitate adherence of cells, cover slides were coated with the positively charged Poly-L-





a 1/10 dilution of Poly-L-lysine in sterile water for 20 minutes. Coverslides were dried and 




3.4.3 Transient transfection of DNA 
Transient transfection of mammalian HeLa P4 cells was used for localization experiments. The 
method was also used to transfect HEK 293T cells in order to overexpress protein for 
immunoprecipitation experiments. An appropriate amount of DNA (see table below) was 
mixed with 250mM calcium chloride (transfection buffer 1) and vortexed for 5 seconds at half 
power. Subsequently, an equal volume of 2x HEPES- phosphate buffer (transfection buffer 2) 
was added and again vortexed for 10 seconds at full speed. The reaction was incubated for 20 
minutes at room temperature and was then added to cells of 50-60% confluency. Cells were 
further incubated for 20 hours to express the gene of interest and then processed for 
immunofluorescence or immunoprecipitation. Transfection of 10cm plates was performed 
using 3 samples for one plate. 
 








3.4.4 RNA-interference (Tuschl et al., 1999; Tuschl, 2001) 
RNA-interference provides a highly specific and efficient method to suppress the expression 
of proteins. A 21 nucleotides long double stranded oligo was designed specifically for the 
protein to be silenced. The sequence of the small interference (siRNA) oligo had to be 
homologous to the coding part of the proteins mRNA.  
 
 
 24 well 10 cm plate (prepare 3 samples) 
CaCl2 (µl) 25 215 
DNA (µg) 1,5 15-20 





Transfection of siRNAs with Oligofectamine (Invitrogen) 
siRNAs were transfected with the Oligofectamine transfection reagent. Cells were plated at a 
confluency of 30-40%, prior to transfection in 24 well plates with 500µl cell-suspension each 
well. SiRNAs were kept at a working concentration of 20µM in nuclease free water. Only the 
transportin siRNA was kept at 10µM according to the manufacturers protocol. 2µl of siRNA 
(final conc. 80nM) was transfected with 1.5µl Oligofectamine and 45µl Optimem per 24-well. 
The reaction was incubated for 25 min at room temperature, added to the cells in 500µl 
medium, and was incubated for 72 h. Cells were then split in a 1:3 or 1:4 ratio on coverslides 
in the morning and were transfected with the relevant plasmids in the evening. Experimental 
analysis was performed the day after, resulting in a total siRNA incubation of 96h. The 
silencing for transportin was done the same way except that 8µl (final conc. 160nM) of siRNA 
was used.  
Silencing of NUP358 was achieved with a retransfection after 2 days of incubation. Cells at 
30% confluency were transfected with 2µl of NUP358 siRNA, 1.5µl Oligofectamine and 45µl 
Optimem as described before on day 1. Cells were then incubated for 48 hours and split 
depending on their density in a 1:5 or in a 1:6 ratio on coverslides on day 3. Splitting was then 
followed immediately by a further transfection of NUP358 siRNA as described before. 
Reporter proteins were transfected in the evening of day 4. Analysis was performed at day 5.  





Indirect Immunofluorescence was used to quantify and analyze localization of proteins within 
cells in steady state. Cells were shortly washed with PBS twice and fixed with 4% 
paraformaldehyde in PBS supplemented with Hoechst 33258 at a concentration of 1:4000. 
Fixation was performed for 15 minutes at room temperature. Cells were again washed two 
times for 1 minute with PBS and then permeabilized with 0.5% triton X-100 in PBS for 10 
minutes at room temperature. The detergent was washed off with two PBS washes. 
Afterwards, unspecific epitopes in the cells were blocked with 1% BSA in PBS for 30 minutes 
at room temperature. For protein detection, cells were incubated with primary antibodies at 





primary antibody was washed off with PBS twice. Subsequently, the appropriate secondary 
antibody was applied at a dilution of 1:1000 and incubated for 45 minutes. Cells were again 
washed two times in PBS, dried and mounted with Dako mounting medium. 
 
 
Incubation of compounds 
Cells were washed with PBS and prostaglandins were applied in an appropriate final 
concentration of 1µM-15µM in 400µl medium without FCS and incubated on the cells for 1 
hour at 37°C. The prostaglandins were kept as a 10mM ethanol stock. LMB was applied at a 
final concentration of 5nM from a stock solution of 5µM also in medium lacking FCS. Cells 
were also incubated for 1 hour at 37°C. Since ethanol was a solvent for the compounds it was 






3.5 Microscopy techniques 
 
3.5.1 Confocal microscopy 
Confocal microscopy was performed using a LSM 510 meta confocal microscope from Zeiss. 
Images were taken with the 63x Plan-Neofluar 1.3 NA water-corrected objective. The filter 
settings were adjusted to the type of fluorescence used in the experiment. For visual 
illumination and analysis, an x-site series 120 lamp was used. Images were taken using 
different lasers for excitation of dyes or fluorescent proteins. The Diode laser provided an 
excitation at 405nm and was used to detect the Hoechst stain. EGFP, YFP and Alexa Fluor488 
antibodies were detected with the Argon 488 laser while the HeNe 594 was used to excite 
Alexa 594-conjugated antibodies. For far red antibodies such as Alexa 647and Alexa 633 the 
HeNe633 was used. While imaging fixed specimen, the pinhole was set between 1-1.5 airy 
units depending on the strength of fluorescence. The scan speed was set to a pixel time of 





scans was set to 4. In order to avoid bleaching, the laser transmission was set to 8% for the 
Diode laser and 12-15% for the Argon and HeNe lasers. 
 
 
3.5.2 Measurement of import and export kinetics (reviewed in Shawn et al., 2005) 
Import and export kinetics of HeLap4 cells were measured by live cell imaging at the confocal 
microscope using a technique called fluorescence loss in photobleaching (FLIP). Cells grown 
on coverslides were transfected with the respective plasmids expressing GFP-fusion proteins. 
The slide was put into a chamber fitting into the attachment of the microscope and cells were 
supplied with CO2- independent medium. The microscope chamber was preheated to 37°C. 
For kinetic measurement, two equally fluorescent cells in close proximity to each other were 
chosen. In one cell the measurement was performed while the other one was referred to as a 
reference cell. The measurement was carried out as a photometric analysis using a set of 200 
single photographs taken between 180 defined bleaching steps within 148 seconds. The first 
20 images were performed without a bleaching interval in between. Once a GFP is bleached, 
it cannot recover within 146 seconds and therefore also not be measured again. Loss of 
fluorescence in a certain compartment of the cell is then due to protein diffusion or active 
transport.  
For this kind of experiment, the pinhole was set to 2.0 airy units to collect as much light as 
possible. Imaging scan speed was set to a minimum pixel time of 1.27µs with an image 
number of 1 which resulted in an image interval of 154ms. The image was taken with a laser 
transmission of 1%. Between the images bleach intervals of 650ms were performed with 
100% laser transmission and an iteration of 70. The bleaching intervals were performed 
within the measured cell in a small ROI (region of interest) of 30x10 pixels. When import 
kinetics were measured, the bleached region ROI-1 was set inside the nucleus of the analyzed 
cell. In contrast, export kinetics were analyzed with the bleached region ROI-1 set in the 
cytoplasm. After performing the measurement, other ROIs were encircled to measure their 
fluorescence intensity. In case of import analysis, ROI-2 was set by encircling the cytoplasm of 
the analyzed cell, ROI-3 was set by encircling the cytoplasm of the reference cell, ROI-4 
marked the background (also see figure S6). For analysis of export kinetics ROI-2 was defined 
by encircling the nucleus of the analyzed cell, ROI-3 was defined inside the nucleus of the 





FLIP sample, the computer program analyzed the loss of fluorescence within the defined ROIs 
in pixel intensities. For each experiment 30-45 FLIPs were performed.  
 
 
FLIP data analysis  
The data from FLIP experiments were analyzed using Microsoft Office Excel 2010. Data were 
plotted by analyzing signal intensities from nuclear regions of a bleached (Fb) and a 
neighboring unbleached cell as a reference (Fr), and a background region (Fc). Nuclear 
fluorescence intensities for each time point were expressed as F(t) = (Fb - Fc)/(Fr - Fc). 
Fluorescence intensities were normalized to 1. Per condition 10–20 cells were analyzed. 
 
 
Data analysis and quantification 
Cellular localization of reporter proteins under different conditions was determined either by 
immunofluorescence or using fluorescent GFP-fusion proteins. For that purpose, cells were 
counted and subdivided into three categories: N>C majority of the reporter protein localizes 
in the nucleus, N<C majority of the reporter localizes in the cytoplasm, N=C equal distribution 
of the reporter. For every analyzed condition, 100 cells were counted and quantification was 
performed from at least three independent experiments. Error bars indicated the standard 
deviation calculated from these three experiments. Statistical significance of the data was 
determined applying a two-tailed and heteroscedastic student´s t-test (White, 1980) All 
calculations were done using Microsoft Office Excel 2010. Images were processed using the 








4) Results  







4.1 Prostaglandin 15-deoxy-Δ12,14-PGJ2 inhibits CRM1 mediated protein export 
Prostaglandins are derivatives of arachidonic acids and contribute mainly to inflammatory 
responses. Cells that produce prostaglandins therefore belong to the immune system of an 
organism, such as T-cells or macrophages. During an inflammatory response these cells 
produce a subset of prostaglandins after stimulation. In this work HeLa cells were used to 
investigate effects of 15d-PGJ2 on CRM1 mediated protein export.  
 
 
4.1.1 15-deoxy-Δ12,14-PGJ2 accumulated in the nucleus 
The fungal inhibitor leptomycin B (LMB) is known for its inhibitory effect on CRM1-mediated 
protein export in mammalian cells (Kudo et al., 1999). LMB binds covalently and highly 
specifically to an evolutionary conserved cysteine residue at position 528 of the CRM1 
sequence. The binding occurs at the sulfhydryl group of the cysteine via Michael addition 
(Kudo et al. 1999). Since LMB is an exogenous factor it was interesting to investigate whether 
endogenous compounds exhibiting a similar structure were also able to show comparable 
effects. In a binding assay using biotinylated 15-deoxy-Δ12,14-PGJ2 (15d-PGJ2) as a bait, CRM1 
was detected as one of the prey proteins (Hilliard et al., 2010). Interestingly, 15d-PGJ2 exhibits 
a very similar structure like LMB (figure 1B). It also contains a fatty acid tail and a 
cyclopentenone ring with a free α,β unsaturated carbonyl group which can potentially react in 
a Michael addition. In previous studies it was shown that biotinylated LMB enters the nucleus 
to target CRM1 (Kudo et al. 1999). If 15d-PGJ2 is able to bind covalently to CRM1 it seemed to 
be possible that also 15d-PGJ2 can be detected in the nucleus. Therefore, HeLa cells were 
incubated with biotinylated 15d-PGJ2 to determine its subcellular localization. Incubation was 
performed in serum-free medium, because 15d-PGJ2 shows a preference to target BSA 
(Rajakariar, 2007). 
To detect the biotinylated 15d-PGJ2 cells were fixed and incubated with streptavidin 488. A 
negative control was performed using untreated cells. In 15d-PGJ2- biotin treated cells, the 
prostaglandin clearly accumulated in the nucleus, which led to the assumption that 15d-PGJ2 
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Figure1: 15-deoxy-Δ
12,14
-PGJ2 accumulates in the nucleus 
(A) HeLa p4 cell were treated with 15µM biotinylated 15d-PGJ2 for 1 hour at 37°C and 5% CO2. Incubation was 
performed in serum-free medium. Cells were fixed, permeabilized and blocked. Biotin was detected using 
Strepavidin488. The control cells were not treated with biotinylated 15d-PGJ2 but were incubated with 
Streptavidin488 to detect possible cross-reactions. Images of the control were taken using the reuse function. 
(Hilliard et al. 2010) (B) Structures of 15d-PGJ2 and LMB. The asterisks mark the free electrons in both cyclic 
compounds available for a Michael addition.  
 
is able to target nuclear proteins (figure 1 A). Within this experiment it became clear that 15d-
PGJ2 entered the nucleus very quickly. The prostaglandin was detectable in cell after only 15 
minutes of incubation (data not shown). 
 
 
4.1.2 CRM1 can be covalently modified by 15d-PGJ2 
Since it became obvious that 15d-PGJ2 can target nuclear proteins it is possible that it can 
bind covalently to the export receptor CRM1 as LMB is known to do. In order to identify a 
binding of 15d-PGJ2 to CRM1 a cell lysate was incubated with biotinylated 15d-PGJ2. The 
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precipitated. Samples were then subjected to SDS-PAGE, followed by Western blotting and 



























-PGJ2 can target CRM1 
All data shown in this figure were published in Hilliard et al., 2010. (A) Western blot analysis of 
immunoprecipitation of a cell lysate incubated with (+) or without (-) biotinylated 15d-PGJ2 bound to 
neutravidin beads. CRM1 was detected by rabbit αCRM1 antibody. 1% of the supernantant (supe) was loaded 
as an input control. This experiment was carried out by Annegret Nath (B) Identified CRM1 peptides out of a 
pool of 15d- PGJ2 modified proteins from a HeLa-cell lysate. Peptides were analyzed by LC-MS/MS. Identitiy of 
peptide LLSEEVFDFSSGQITQVK was confirmed by sequencing. The experiments of figure 2B and 2C were carried 
out by Marc Hilliard. (C) Full mass spectrum of the modified CRM1 peptide DLLGLCEQK treated with 15d-PGJ2. 
Arrows indicate the peaks of the modified peptide double charged (667.55) and singly charged (1334.00). 
Arrowheads indicate peaks of the same peptide unmodified. The difference in weight of the unmodified single 
charged peptide at 1017.82 and the 15d-PGJ2 modified single charged peptide at 1334.00 corresponds to the 
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15d-PGJ2 (figure 2 A). To confirm results that CRM1 was targeted by the prostaglandin, a LC-
MS/MS mass spectrometry approach was performed from precipitated proteins using the 
same precipitation method as described above. Indeed several CRM1 peptides were found, 
identifying the nuclear export receptor as a target of 15d-PGJ2 (figure 2 B). 
To further analyze whether the modification by 15d-PGJ2 occured at the same amino acid 
(528) of CRM1 as the modification by LMB, a synthetic peptide (aa at position 523-531) 
carrying the sensitive cysteine was incubated with 15d-PGJ2 and later analyzed by mass 
spectrometry. The full mass spectrum showed peaks at m/z 1017 corresponding to the 
unmodified peptide and m/z 1334 corresponding to the modified peptide, both of single 
positive charge (figure 2 C). The difference in weight between the peptides corresponded to 
the molecular weight of 15d-PGJ2, showing that this CRM1 peptide was modified by 15d-PGJ2. 
The peaks shown at m/z 509 and m/z 667 correspond to the unmodified and modified 
peptide with a double positive charge. Taken together, these data showed that the nuclear 
export receptor CRM1 can be targeted by 15d-PGJ2 at the same cysteine residue as LMB. This 
led us to the hypothesis that also 15d-PGJ2 can inhibit CRM1 mediated protein export (Hilliard 
et al., 2010). 
 
 
4.1.3 15d-PGJ2 inhibits nuclear export of overexpressed CRM1 substrates  
To monitor a putative inhibitory effect of 15d-PGJ2 on CRM1 mediated protein export in vivo, 
experiments with overexpressed reporter proteins were performed. The GFP-tagged 
transcription factor TFIIAα was overexpressed and tested for changes in localization after 
treatment with 15d-PGJ2. TFIIAα-GFP was known from previous experiments to be localized 
predominantly to the cytoplasm and to respond to LMB treatment with nuclear accumulation. 
As shown in figures 3A, the CRM1 inhibitor LMB led to an accumulation of the reporter in the 
nucleus while cells treated with the ethanol control showed the original localization of the 
reporter in the cytoplasm. This suggested that export of GFP-TFIIAα is mediated by CRM1. 
Application of 15d-PGJ2 also led to an accumulation of TFIIAα-GFP in the nucleus (figure 3 A). 
Figure 3B shows a quantification of this experiment. After treatment with the very potent 
CRM1 inhibitor LMB, quantification showed a strong localization of the reporter in the 
nucleus. Quantification of 15d-PGJ2 treated cells showed a nuclear localization of the reporter 
in around 30% of the analyzed cells while more than 60% showed an equal distribution of the 
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Figure 3: Export of TFIIAα is inhibited by 15d-PGJ2 
(A) Prior to fixation TFIIAα-GFP transfected HeLa p4 cells were treated with either 15µM 15d-PGJ2 or 5nM 
leptomycin B (LMB) in serum-free medium for 1 hour. Ethanol (ETOH) was used as a solvent control. (B) 
Quantification of TFIIAα-GFP after treatment with the compounds mentioned above. For every condition 100 
cells were counted from 3 independent experiments. 
 
 
reporter between cytoplasm and nucleus. In less than 10% of the cells GFP-TF2Aα still 
localized to the cytoplasm. This suggested that 15d-PGJ2, like LMB, can also impair the export 
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To strengthen evidence that CRM1 can be modified by 15d-PGJ2 an artificial reporter protein 
solely exported by CRM1 was used. The protein corresponding to the plasmid GFP2-NES was 
overexpressed in HeLa cells which were then treated with either 15d-PGJ2 or different 
prostaglandins (figure 4 A). Incubation with other prostaglandins was performed to test 
whether the previous shown inhibitory effect of CRM1 is due to a specific modification by 
15d-PGJ2 or whether prostaglandins in general can modify the protein. Therefore, a subset of 
endogenously produced cyclic prostaglandins with and without a free electron pair in their 
cyclopentenone ring, were tested (figure 4 A). As a negative control, the compound Cay 
10410 was used which has a similar structure to 15d-PGJ2 but lacks a free electron pair in its 
cyclopentenone ring (figure 4 A). To control the dependency of the reporter on CRM1, LMB 
was again used as a positive control. It was also useful to control the quality of export 
inhibition and to compare and quantify the putative inhibitory effect of 15d-PGJ2.  
Figure 4 A shows the different localizations of GFP2-NES in steady state after treatment with 
different prostaglandins. Representative images are shown in figure 4A, the quantification of 
the experiment is shown in figure 4 B. As is obvious in the ethanol control, the reporter 
plasmid predominantly showed an equal distribution between nucleus and cytoplasm or 
localized to the cytoplasm exclusively. Following LMB treatment more than 60% of the 
analyzed cells the reporter accumulated in the nucleus. Also after 15d-PGJ2 treatment more 
than 45% of the cells showed a nuclear accumulation of GFP2-NES whereas the rest of the 
cells showed an equal distribution and only in few cells the reporter still localized to the 
cytoplasm (figure 4 B).  
The other tested prostaglandins showed little or no influence on localization of the reporter 
protein. In case of prostaglandin E2 (PGE2) localization did not change significantly. The non-
reactive 15d-PGJ2 analog CAY 10410 and prostaglandin A (PGA) showed an equal distribution 
of the reporter with little influences on its localization. Although PGA also exhibits a free 
electron pair in its cyclopentenone ring it apparently cannot inhibit CRM1 mediated protein 
export in the same way like 15d-PGJ2. Taken together, these in vivo data with an artificially 
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Figure 4: CRM1 export substrate GFP2-NES is inhibited by 15d-PGJ2 
(A) Prior to fixation GFP2-NES transfected HeLa p4 cells were treated with different compounds for 1 hour in 
serum-free medium. Structures of the relevant compounds are shown next to the images. Asterisks mark free 
electron pairs in the cyclopentenone ring structure. LMB was used as a final concentration of 5nM while 
prostaglandins and CAY 10410 were used at 15µM. Ethanol (ETOH) was used as a solvent control. (B) 
Quantification of localization of GFP2-NES after treatment with the compounds mentioned above. For each 
condition, 100 cells were counted from at least 3 independent experiments. Error bars showed the standard 
deviation of these three experiments. 
 
 
4.1.4 15d-PGJ2 inhibits CRM1 mediated export of endogenous RanBP1 
Since 15d-PGJ2 was able to impair the export of overexpressed proteins in vivo, the question 
arose whether the prostaglandin treatment also led to the nuclear accumulation of 
endogenous CRM1 export substrates. Therefore, RanBP1 a known NES containing CRM1 
substrate (Richards et al. 1996) was analyzed. HeLa cells were incubated with several 
prostaglandins, LMB, Cay10410, ethanol and hydrogen-peroxide for 1 hour in serum-free 
medium. Hydrogen-peroxide was used to exclude changes in protein localization due to 
oxidative stress, which is known to occur after 15-PGJ2 treatment (Kondo et al., 2001) and 
therefore validate the inhibitory effect of 15d-PGJ2 on CRM1. After treatment with the 
different compounds cells were subjected to immunofluorescence and RanBP1 was detected 
using a specific antibody. Localization of RanBP1 was subsequently quantified. RanBP1 
localized exclusively to the cytoplasm in the ethanol control as well as in the hydrogen-
peroxide treated sample implying no influences on protein localization after induction of 
oxidative stress. After treatment with LMB, RanBP1 strongly accumulated in the nucleus 
(figure 5A, 5B). As shown in the quantification, all prostaglandins had a clear effect on 
localization of RanBP1. But compared to the effects of PGA and 15d-PGJ2 the prostaglandin 
PGE2 showed the weakest effect on RanBP1 localization. Still more than 50% of the analyzed 
cells showed a cytoplasmic localization of RanBP1. After incubation with PGA localization of 
RanBP1 was shifted to a 50% equal distribution of the export factor between cytoplasm and 
nucleus. The inhibitory effect of 15d-PGJ2 was again stronger showing that this prostaglandin 
can also inhibit CRM1-dependent export of endogenous proteins. The modification of CRM1 
through a Michael-addition by 15d-PGJ2 appeared more likely considering the localization of 
RanBP1 after CAY10410 treatment, which lacked the α,β unsaturated carbonyl-group in the 
cyclopentenone-ring. In contrast to 15d-PGJ2, CAY10410 did not change the localization of 
RanBP1, suggesting a Michael- addition of the reactive group at CRM1. 
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Figure 5: 15d-PGJ2 inhibits CRM1 mediated export of endogenous RanBP1 
(A) Prior to fixation, HeLa p4 cells were treated with 15d-PGJ2, LMB, Prostaglandin A (PGA), ProstaglandinE2 
(PGE2), CAY 10410, ethanol as a solvent control and H2O2 for 1 hour at 37°C in serum-free medium. All 
prostaglandins and CAY were used at a final concentration of 30µM. LMB was used at a final concentration of 
5nM and hydrogen-peroxide was incubated in a final concentration of 10µM. RanBP1 was detected using a 
mouse α RanBP1 antibody at a concentration of 1:100 at 4°C overnight. (B) Quantification of RanBP1 
distribution after incubation of compounds on cells. For each condition, 100 cells were counted from at least 




4.1.5  The CRM1 export substrate NC2β is very sensitive towards 15d-PGJ2 export inhibition 
In the previous experiments, 15d-PGJ2 was used in high, non-physiologically relevant 
concentrations. Since prostaglandins are synthesized by cells in low nanomolar concentrations 
(Rouzer et al. 2005) it was interesting to find export substrates which responded to much 
lower concentrations of 15d-PGJ2. 
To investigate this, different CRM1 substrates were tested and the transcription factor RFP-
NC2β (negative cofactor 2β) was found to differ in its subcellular localization after incubation 
with comparatively low levels of 15d-PGJ2. NC2β was described as a nuclear-cytoplasmic 
shuttle and as a CRM1 dependent export substrate exhibiting a functional NES in its N-
terminus (Kahle et al. 2009).  
In control cells treated with ethanol, RFP-NC2β localized to the nucleus and cytoplasm quite 
homogenously. Transfected cells were treated with LMB to detect CRM1 mediated export. 
After treatment with LMB, RFP-NC2β accumulated very strongly in the nucleus (figure 6A) 
confirming a CRM1 mediated export of the substrate. 15d-PGJ2 was incubated with RFP-NC2β 
transfected HeLa cells using different final concentrations ranging from 100nM to 2µM. Figure 
6B shows a quantification of cells where RFP-NC2β accumulated in the nucleus. After 
incubation with a final 15d-PGJ2 concentration of 200nM, around 12% of the transfected cells 
showed a nuclear accumulation of the reporter protein. When the 15d-PGJ2 concentration 
was raised to 500nM one third of the analyzed cells showed a nuclear accumulation of RFP-
NC2β (figure 6B).  
Taken together, these data showed that indeed even low concentrations of 15d-PGJ2 can 
affect the localization of certain CRM1 substrates. 
 
 
4) Results  
























Figure 6: RFP-NC2β accumulates in the nucleus at low concentrations of 15d-PGJ2 
(A) HeLa p4 cells were transfected with RFP-NC2β and treated with either a final concentration of 5nM LMB or 
ethanol as a solvent control for 1 hour at 37°C in serum-free medium. Cells were then fixed and their DNA 
stained with Hoechst. (B) Quantification of RFP-NC2β transfected cells following a titration of 15d-PGJ2 and 
fixation. Only numbers of N>C cells are shown in this graph. Prior to fixation cells were treated with ethanol as 
a solvent control (0nM 15d-PGJ2), 100nM 15d-PGJ2, 200nM 15d-PGJ2, 500nM 15d-PGJ2, 1µM 15d-PGJ2 and 2µM 
15d-PGJ2. Quantification was carried out by counting 100 cells per experiment which was repeated at least 
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4.1.6 In vivo analysis of export kinetics by live cell imaging 
To further analyze inhibition of CRM1 mediated export by 15d-PGJ2 treatment export kinetics 
were performed with life cell imaging using the FLIP (fluorescence loss in photo bleaching) 
method. This method documents the loss of fluorescence of a GFP-tagged protein in one cell 
compartment (nucleus) while another one (cytoplasm) is bleached. The loss of fluorescence in 
a cellular compartment is either due to diffusion or active transport of the fluorescent 
protein. For this kind of analysis, the reporter plasmid coding for NES-GFP2-M9 was 
transfected into HeLa cells. This construct contained a functional NES from the HIV-1 Rev 
protein, which is recognized and exported by CRM1 while it is imported by transportin via its 
 
 









Figure 7: Life cell imaging performance showing CRM1 export inhibition by 15d-PGJ2 using FLIP 
HeLa p4 cells were transfected with the shuttling reporter protein NES-GFP2-M9. Prior to analysis, cells were 
treated with either LMB (5nM), 15d-PGJ2 (15µM) or ethanol as a solvent control. The compounds were 
incubated with the cells in serum-free medium for 1 hour at 37°C and 5% CO2. Before starting the analysis the 
medium was changed to CO2 independent medium. Asterisks in the images mark the bleached region in the 
cytoplasm. The assay was performed in three independent experiments analyzing 15-20 cells each. Error bars in 
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M9 sequence. In control cells, this protein showed a nuclear localization so the loss of 
fluorescence in the nucleus could be measured easily. After transfection, cells were either 
incubated with LMB, 15d-PGJ2 or ethanol as a solvent control.  
In control cells, it took 52.8 seconds until nuclear fluorescence was reduced to 50%. In cells 
treated with 15d-PGJ2 it took 110.7 seconds, (figure 7). This showed that nuclear export of 
CRM1 can be inhibited by 15d-PGJ2 in living cells. The well-established CRM1 inhibitor LMB 
gave a fluorescence of 54% after 146.3 seconds at the very end of the measurement. The 
import of the shuttling protein was not affected (figure S3). The images taken from the FLIP 




4.1.7  The CRM1 mutant C528S can rescue CRM1 substrate mis-localization due to export 
inhibition by 15d-PGJ2 
LMB inhibits CRM1-mediated protein export by binding to its sensitive cysteine at amino acid 
528 of the human sequence. The CRM1 protein from the yeast Saccharomyces pombe is 
resistant to LMB targeting due to the presence of a serine at this position (Kudo et al., 1999). 
To investigate whether 15d-PGJ2 used the same mechanism to modify CRM1, a LMB resistant 
Ha-tagged CRM1 C528S mutant was used. The mutation of the cysteine to a serine has no 
influences on CRM1 export capabilities. CRM1 C528S was cotransfected with CRM1 
dependent export substrates and the localization of the substrates was analyzed after 
treatment with LMB, 15d-PGJ2 or ethanol. To control and quantify the effect, wild-type Ha-
CRM1 was also cotransfected with the same reporter proteins. If CRM1 modification by 15d-
PGJ2 occured at the same residue as in LMB, then CRM1 C528S should be able to rescue the 
inhibitory effect of 15d-PGJ2 on the reporter proteins. One day after transfection the cells 
were treated with either 15d-PGJ2, LMB or ethanol for 1 hour. After fixation cotransfected 
cells were imaged and quantified. In the ethanol control the CRM1 dependent reporter 
protein TFIIAα-GFP localized to the cytoplasm in the presence of CRM1 WT as well as CRM1 
C528S (figure 8A/B) showing that overexpressed CRM1 did not influence its localization 
(compare figure 3). After treatment with the CRM1 inhibitor LMB, a clear nuclear 
accumulation of the reporter in cells with CRM1 WT was detectable and quantifiable, while 
cells with CRM1 C528S showed rescue of the localization of the reporter (50% less nuclear 
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accumulation) (figure 8A/B). After 15d-PGJ2 treatment, localization of GFP-TFIIAα in cells with 
CRM1 WT was equally distributed between nucleus and cytosol in 60% of cells. However, in 
cells expression the CRM1 C528S mutant almost 70% of cells showed cytoplasmic localization 
of GFP-TFIIAα due to the inhibitory effect of 15d-PGJ2. This experiment showed that the 
exchange of the cysteine to a serine at position 528 can rescue CRM1 mediated protein 
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Figure 8: CRM1 C528S rescues CRM1 export substrates from 15d-PGJ2 inhibitory effects. 
(A) Rescue of GFP-TFIIAα localization by CRM1 C528S mutant. HeLa p4 cells were cotransfected with GFP-
TFIIAα and Ha-CRM1 WT or Ha-CRM1 C528S. Prior to fixation, cells were treated with 15µM 15d-PGJ2, 5nM 
LMB or ethanol (ETOH) for 1 hour in serum-free medium. Ha-CRM1 was detected with a mouse α Ha. DNA was 
stained with Hoechst. (B) Quantification of (A). For each condition, 100 cells were counted from three 
independent experiments. Error bars show the standard deviation. (C) Rescue of GFP2-NES by CRM1 C528S. 
HeLa p4 cells were cotransfected with GFP2- NES and Ha-CRM1 WT or Ha-CRM1 C528S. After transfection, cells 
were treated as described in (A). To detect Ha-CRM1, the same antibody was used as described in (A). (D) 
Quantification of (C) with 100 cells counted for each condition from 3 independent experiments. Error bars 
show the standard deviation. 
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the same cysteine residue as LMB. To confirm these data, the experiment was repeated with 
the artificial CRM1 export substrate GFP2-NES. Again the reporter was cotransfected with 
either Ha-CRM1 WT or Ha-CRM1 C528S and treated with the respective compounds. 
Overexpressing CRM1 WT as well as the mutant CRM1 C528S again did not significantly 
influence the localization of GFP2-NES in the ethanol control (compare figure 8D to 4B). 
Treatment with LMB again affected the localization of the reporter with coexpressed CRM1 
WT by altering the former mainly cytoplasmic localization to a nuclear accumulation. In 
contrast, overexpression of LMB resistant CRM1 C528S rescued the inhibitory effect on CRM1 
export completely (figure 8C/D). In cells cotransfected with GFP2- NES and CRM1 WT 
treatment with 15d-PGJ2 also influenced the localization of the reporter significantly by 
shifting the cytoplasmic localization to an equal distribution or even causing a nuclear 
accumulation. By overexpressing the CRM1 C528S this effect was also rescued completely and 
the reporter showed a distribution comparable to that seen with the ethanol control (figure 
8C/D). This demonstrated that 15d-PGJ2 is able to modify CRM1 at cysteine 528, as is seen 
with LMB. This experiment also indicates that cysteine 528 is probably the only amino acid to 
be targeted by the prostaglandin that can be involved in inhibiting export efficiency, since the 
exchange of this single cysteine to a serine led to a complete rescue of the inhibitory effect of 
15d-PGJ2 using the CRM1-dependent reporter GFP2-NES.  
All previous experimental data show that prostaglandin 15d-PGJ2, which can be produced 
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4.2 Analysis of human telomerase reverse transcriptase import 
 
Human telomerase reverse transcriptase is a ribonucleoprotein which consists of a protein 
subunit (TERT) and a RNA component (TER) (Blackburn et al. 1989; Lamond 1989). 
Telomerase is a conserved enzyme that is involved in chromosome maintenance and 
telomere elongation by synthesizing the telomeric TTAGGG repeats (Greider et al., 1989; 
Morin 1989, Blackburn et al. 1989). It therefore has to enter the nucleus through the nuclear 
pore. In contrast to very small proteins that can diffuse freely through the pore a protein like 
hTERT needs to be transported actively.  
Here in this work it has been shown that factors such as an import receptor and a distinct 




4.2.1 Overexpressed TERT localized to the nucleus independently of its tag 
To determine the subcellular localization of overexpressed TERT in HeLa cells and to 
investigate possible influences of tags on the localization of the protein, several plasmids 
coding for differently tagged TERT proteins were used. C-terminally located YFP- GFP- and HA-
tags were used to detect TERT localization within the cells. While cells transfected with 
fluorescent YFP and GFP fusion constructs were fixed and mounted, the HA-tagged version 
was detected using indirectly immunofluorescence. 
The YFP and GFP tagged versions of TERT localized to the nucleus almost exclusively. The 
smaller TERT-HA protein also showed a nuclear localization (figure 9). This data showed that 
the size of the tag did not affect the subcellular localization of overexpressed TERT.  
This experiment showed that the overexpressed human TERT constructs used in this work 
localized to the nucleus of human cells similar to the endogenous human TERT (shown in 
Chung et al., 2012; Haendeler et al., 2003). This indicates the protein therefore needs to be 
recognized, bound and imported into the nucleus by import receptors, since it is too large to 
diffuse into the nucleus. 
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Figure 9: Overexpressed TERT localizes to the nucleus 
HeLa cells were transiently transfected with different TERT expression plasmids. Cells transfected with 
fluorescent YFP- and GFP- tags were fixed and mounted. The HA tag was detected using a specific mouse α Ha 




4.2.2 Identification of a specific NLS-motif in human TERT 
Since we observed that overexpressed TERT entered the nucleus it became obvious that it 
needed to be transported actively. Free diffusion of proteins through the nuclear pore is 
possible for small proteins of low molecular weight.  
To determine which region of TERT is responsible for its import, several truncation mutants of 
TERT were cloned into a GFP-vector. The construct GFP-TERT NT containing amino acids 1-
600 comprised the whole NTE including the TEN- and the TRBD-domains. The truncation 
mutant GFP-TERT CT comprised the amino acids 601-1132 and included the RT motifs and the 
C-terminal extension. For a schematic description of the mutants see figure S4. 
In HeLa cells the TERT N-terminus as well as the C-terminus localized to the nucleus (figure 
10A). This implied the existence of nuclear localization signals or importin docking sites in 
both truncation mutants. In an attempt to determine a responsible and distinct region for 
import within the TERT protein, further truncation mutants of the N-terminal region were 
cloned. For this purpose, several stretches of the proteins N-terminus were fused to a N-
terminal GFP or double GFP-tag. GFP/dGFP-TERT 1-150 comprised parts of the N-terminal 
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shortly before the telomerase RNA binding site (TRBD). The last N-terminal truncation mutant 
GFP/dGFP-TERT 301-600 includes the full TRBD and ends before the RT motifs. As shown in 
figure 10B all of the N-terminal truncation mutants localized to the nucleus exclusively, 


































Figure 10: Overexpressed TERT truncation mutants localized to the nucleus exclusively 
(A) TERT N-terminus and C-terminus localize to the nucleus. HeLa cells were transiently transfected with the 
respective GFP fusion plasmids. Cells were fixed and mounted. DNA was stained with Hoechst. 
(B) TERT N-terminal fragments localize to the nucleus. HeLa cells were transiently transfected with the 
respective GFP or dGFP fusion constructs. Cells were fixed and mounted. DNA was stained with Hoechst. In 
contrast to all other TERT truncation mutants, which localized homogenously to the nucleus, TERT 301-600 
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Based on these observations, we decided not to work with small truncation mutants anymore 
and to follow a different strategy. A motif scan on the protein sequence of TERT was 
performed to identify putative recognition motifs for transport receptor binding. Indeed, the 
motif scan (www.elm.eu.org) identified a NLS motif located within the N-terminal region of 
TERT stretching from amino acids 235-240 (PKRPRR) similar to the classical NLS (figure 11A). 
To validate whether this putative NLS is a functional motif, amino acids 239 and 240 were 
mutated to alanines (RR      AA). Quantification of the localization of the mutant (GFP-TERT-NT 
239) showed no difference in localization compared to wild type GFP-TERT-NT (figure S5). This 
result led to the conclusion that the two arginine residues were not essential for nuclear 
import. Next, the residues KR at positions 236 and 237 were also mutated to alanines yielding 
the sequence KRPAA       AAPAA and destroying the whole putative NLS- site. Quantification of 
this mutant compared to wild type GFP-TERT-NT gave the first hints for an import defect. 
Around 1/3 of the analyzed cells showed an equal distribution of the overexpressed protein 
between nucleus and cytoplasm whereas wild type GFP-TERT-NT was located in the nucleus 
exclusively (figure S5). This indicated that residues 236 and 237 (KR) could be responsible for 
the import of GFP-TERT-NT. 
To analyze whether these residues also play a role in the import of the full length protein, 
TERT-GFP was also subjected to site-directed mutagenesis and residues 236 and 237 were 
mutated to alanines resulting in the sequence (KRPRR      AAPRR) leaving the last two arginines 
intact. After transfection, the mutant showed a severe import defect with predominantly 
equal distribution of the protein between nucleus and cytoplasm. The number of cells 
showing a nuclear localization dropped below 10% (figure 11 B/C). This demonstrated that 
indeed the amino acid sequence 236-240 in TERT is a functional NLS motif with amino acids 
236 and 237 as a KR motif required for the import of the full length protein. While this work 
was in progress the same NLS motif in human TERT was discovered by another group (Chung 




4.2.3 Identification of a second NLS in TERT 
In the last experiment, the existence of an N-terminal NLS in human TERT was demonstrated 
but mutation of this NLS did not completely lead to exclusion of the protein from the nucleus. 
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From these results it can be concluded that either residual binding to the NLS occurred or at 
least one additional NLS motif must exist within the protein. Since the residues KR were 
predominantly responsible for import in the N-terminally identified motif, a manual search for 
other KR motifs within the protein sequence was carried out. Indeed two other sites were 
found. The first one is located at amino acids 594-599 (KRVQLR) and the second one was 
found at  position 649-653 (KRAER) (figure 11D). Also here KR motifs were mutated separately 
to establish whether they are functional NLS sites and contribute to import of TERT.  
First, the KR motif at 594-595 was mutated to alanines by site-directed mutagenesis. The 
corresponding protein was overexpressed in HeLa cells and accumulated in the nucleus 
predominantly (data not shown) demonstrating that the KR motif at position 594/595 does 
not form a functional NLS motif in TERT-GFP.  
Next, the downstream KR motif at position 649/650 was mutated to alanines by site directed 
mutagenesis. HeLa cells were transiently transfected with the resultant mutant and 
quantification of transfected cells showed a defect in nuclear accumulation of the mutant. 
Only 63% of cells showed a nuclear accumulation of TERT 649 KR-AA-GFP while the rest 
showed an equal distribution between nucleus and cytoplasm (25%) or a cytoplasmic 
localization (11.5%, figure 11 B/C). This result suggested that human TERT-GFP exhibits more 
than one NLS although the newly identified NLS seemed to be a much weaker one than the 
motif at position 236/ 237.  
To investigate whether the import defect enhances after mutation of both motifs a double 
mutant was created. The N-terminal (236/237) as well as the C-terminal (649/650) motif was 
mutated resulting in the clone TERT KR 236/237 AA KR 649/650 AA- GFP (TERT 236 649 KR-
AA-GFP). Quantification of this mutant resulted in an enhanced cytoplasmic localization of the 
double mutant compared to the N-terminal single mutant TERT 236 KR-AA-GFP (figure 11 
B/C). 
To further analyze the import inhibition by the destroyed motifs and to demonstrate the 
reduced kinetics, a FLIP experiment was performed. HeLa cells were transiently transfected 
with either TERT-GFP, TERT 236 KR-AA-GFP or TERT 236 649 KR-AA-GFP. Living cells were 
bleached  in  the nucleus  and the loss  of fluorescence  from the cytoplasm caused by  import 
of  the  protein  was determined. 
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Figure 11: Identification of a second NLS motif in TERT 
(A) The amino acid sequence of human TERT was run in a protein motif scan (www.elm.eu.org) and a putative 
NLS was discovered. 1) N-terminal sequence in human TERT from amino acids 220-250. 2) Bipartite NLS motif 
that was found through the in silico scan comprising amino acids 222-240. 3) Monopartite NLS motif within the 
bipartite motif, which was also discovered by the bioinformatics analysis. (B) HeLa p4 cells were transiently 
transfected with TERT-GFP or the mutants TERT 236 KR-AA-GFP, TERT 619 KR-AA-GFP or the double mutant 
TERT 236 649 KR-AA-GFP. After fixation DNA was stained with Hoechst and cells were subjected to 
quantification and imaging. The white arrow points to cells showing an import defect of TERT 649 KR-AA-GFP 
transfected cells. The red arrow points to a cell classified as nuclear accumulation but compared to wild type 
TERT-GFP it becomes obvious that a lot of protein resides in the cytoplasm suggesting a slower import than 
wild type TERT-GFP. (C) Quantification of TERT-GFP and the NLS mutants mentioned above. TERT-GFP was 
quantified from 14 independent experiments. Quantifications were fused and shown as a mean value with 
standard deviations from all these experiments. TERT 236 KR-AA-GFP and TERT 236 649 KR-AA-GFP were 
quantified from 3 independent experiments counting 100 cells each. TERT 649 KR-AA-GFP was quantified 
counting 800 cells from 3 independent experiments. Error bars show the standard deviation of three 
experiments. (D) Schematic description of human TERT with its putative NLS sites.  
 
 
Mean values of 45 measured cells for each time point and condition are shown in figure 12.  
After t=146  seconds,  TERT-GFP  fluorescence  was reduced from the initial level of 1.0 to 
0.36, a great loss of fluorescence suggesting a high import rate (figure 12). At the same 
timepoint, the remaining fluorescence of TERT 236-KR-AA-GFP was still 0.61. This 
demonstrated that import kinetics decreased after destruction of the NLS site compared to 
WT TERT-GFP.  
In the double mutant TERT 236 649 KR-AA-GFP this effect was even enhanced, resulting in a 
value of 0.72 after 146 seconds, showing that import further decreased after mutation of the 
second KR motif (figure 12). These findings led to the conclusion that TERT-GFP contains 
another NLS site at position 649/650. However, the strongest NLS motif in TERT is the one 
found at 236-240 with the KR motif responsible for its import. 
Regarding the export rate of TERT-GFP (see figure S7), it became obvious that the protein 
does not underlie a strong export rate during analysis. Studies suggested that TERT is 
exported by CRM1 (Seimiya et al., 2000), but after incubation with LMB, export rate did not 
change much. This led us to the assumption that export of TERT-GFP does not occur at a fast 
rate. 
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Figure 12: Inhibited import of the NLS mutants can be demonstrated in living cells 
HeLa cells were transiently transfected with TERT-GFP, TERT 236 KR-AA-GFP or TERT 236 649 KR-AA-GFP. White 
asterisks in the nuclei indicate the bleached regions. For every condition 45 cells were analyzed. Error bars in 
the diagram were left out for better clarity of experimental data (Error bars shown in figure S11). In order to 
gain comparable data, cells with equal levels of fluorescence in their cytoplasm were chosen in mock as well as 
in KD cells (figure S6). The red arrow marks the darkened cytoplasm of the bleached TERT-GFP transfected cell 
after 146 seconds. The red arrowheads point to the relatively bright cytoplasm of cells transfected with the 




4.2.4 Knock-down of Nup358 results in TERT import defects 
Nup358 (RanBP2) is a 358 kDa protein located at the cytoplasmic filaments of the nuclear 
pore complex (Wu et al., 1995). In recent data it has been shown that this nucleoporin is 
involved in import of some proteins because depletion of Nup358 led to a cytoplasmic 
localization of a subset of import substrates (Wälde et al., 2012). As already described, the 
depletion of Nup358 also led to a cytoplasmic or equal distribution of overexpressed TERT-
myc (Hutten 2007) suggesting that the lack of Nup358 led to impaired import of TERT. In the 
















   
seconds 
Import of TERT NLS mutants 




TERT 236 KR-AA-GFP 





0.00 sec 146.168 sec 
4) Results  




Endogenous Nup358 was depleted by siRNA treatment. Cells were then transiently 
transfected with TERT-GFP and subjected to immunofluorescence. Nup358 was stained with a 
specific antibody to determine knock-down efficiency. Only cells with significantly reduced 
Nup358 were analyzed. 
Figure 13B and the quantification (figure 13C) show a typical localization of TERT-GFP in mock 
and Nup358 depleted cells. In control cells (white asterisk) TERT-GFP accumulated in the 
nucleus almost exclusively while in Nup358 depleted cells (red arrow) TERT-GFP either 




4.2.5 Overexpressed Nup358 fragments containing the zinc-fingers efficiently rescued TERT 
From the previous experiment, it was known that Nup358 was required for TERT nuclear 
import. The question arose, which region of Nup358 is responsible for the import of TERT-
GFP. In previous work, Nup358 siRNA resistant truncation mutants of the nucleoporin have 
been cloned and certain domains of its N-terminus containing aa 1-1170 (ending before the 
Ran-binding domain1 (RB1) and including three FG-repeats) were described as the region 
responsible for import of DBC-1, (Wälde 2010). Using the same approach, a similar rescue 
experiment for TERT-GFP was carried out using different fragments of Nup358. Endogenous 
Nup358 was depleted by siRNA treatment and cells were cotransfected with Ha-tagged 
Nup358 fragments (figure 13 A) and TERT-GFP. The siRNA treatment against Nup358 again 
showed a severe impact on TERT-GFP nuclear localization (figure 13 B/C). Less than 30% of 
the analyzed cells showed a nuclear accumulation of TERT-GFP in knock-down cells. In mock 
cells more than 90% of the analyzed cells showed a nuclear accumulation of TERT-GFP. Cells 
cotransfected with Nup358 fragments showed different localizations of TERT-GFP depending 
on the fragment. The largest fragment without any rescue effect was Nup358 1-1306 
containing the leucine rich N-terminus, the coiled-coil domain, FG-repeats (I) and the Ran-
binding domain1 (figure 13 A/C). In contrast to the data for DBC-1 this fragment was not able 
to rescue the import of TERT-GFP in cells depleted of endogenous NUP358. Nuclear 
accumulation of TERT-GFP was observed only in 35.3% (mean value) of the cells (figure 13 
B/C).  A longer fragment was analyzed Nup358 1-1810      
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Figure 13: Overexpression of Nup358 fragments can rescue TERT-GFP 
(A) Schematic description of full length Nup358 and the N-terminal Ha tagged fragments and their domains. 
CC= coiled coil domain, I= FG-repeat, RB= Ran binding domain. (B) HeLa p4 cells were subjected twice to siRNA 
treatment against Nup358 and were then cotransfected with TERT-GFP and Ha-Nup358 fragments respectively. 
Following fixation endogenous Nup358 was detected with a goat α Nup358 antibody and stained with a donkey 
α goat 594 antibody. Ha-Nup358 fragments were detected using a mouse α Ha antibody and stained with a 
donkey α goat 647 antibody. The red arrows point to a group of cells depleted for Nup358 showing the import 
defect on overexpressed TERT-GFP. The white asterisk marks two cells without Nup358 depletion and correct 
localization of TERT-GFP. (C) Quantification of cells from three independent experiments counting 100 cells 
each was done. Knock down efficiency was controlled visually in the immunofluorescence by analyzing cells 
with clearly reduced expression levels of Nup358. Error bars indicate the standard deviation from the mean 
value of the experiments. 
 
containing the zinc finger domain, which showed  the ability to rescue  TERT-GFP  localization.  
Around 66% of the analyzed cotransfected cells showed a nuclear accumulation of TERT-GFP. 
The percentage of cells with cytoplasmic localization was also decreased to an average value 
of 5.3 % (figure 13 B). Transfection of a larger Nup358 fragment containing aa 1-2148 and the 
Ran-binding domain2 enhanced the rescue effect on TERT-GFP resulting in 84% of cells 
showing nuclear accumulation of TERT-GFP (figure 13 B). This experiment showed that indeed 
Nup358 is involved in TERT-GFP nuclear import since the import defect can be specifically 
rescued by overexpression of zinc finger domain containing Nup358 fragments after Nup358 
depletion. This also showed that although various proteins depend on Nup358 for efficient 




4.2.6 Importin-7 is the major import receptor for human TERT 
It was shown that TERT exhibits functional NLSs and its import is dependent on the presence 
of Nup358 (Hutten 2007). The question arose, which import receptor is responsible for the 
import of TERT. In the computational motif scan the N-terminal NLS in TERT was classified as a 
classical NLS (cNLS) basically recognized by importin-β or the importin-β/-α heterodimer 
(Adam et al., 1994). It would be therefore possible that importin-β or the importin-β/-α 
heterodimer serves as the responsible import factor for TERT. 
To identify the import receptor of TERT, knock down experiments using siRNAs directed 
against the import receptors importin-β/ -7/ -9 were performed. HeLa cells were treated with 
siRNAs to reduce the expression level of the import receptors. Control cells were either 
treated with a random non-targeting siRNA or left untreated (mock), were transiently  
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Figure 14: importin-7 is the import receptor for human TERT 
(A) HeLa cells were transfected with siRNAs for different import receptors and incubated for 72 hours. Cells 
were transiently transfected with the following plasmids: TERT-GFP, myc-EZI, NES-GFP2-M9 and NES-GFP2-NLS. 
The artificial import substrate NES-GFP2-NLS also served as a visual control for importin-β knock down. Knock 
down efficiency for transportin was controlled by quantification of NES-GFP2-M9 localization. (B) Quantification 
of (A). For every condition at least three independent experiments were analyzed counting at least 100 cells 
each. Mean values from these experiments with its subdivisions are shown in the diagrams. Standard 
deviations are shown as error bars. 
 
transfected with either TERT-GFP or control plasmids such as EZI or the artificial import 
substrates NES-GFP2-cNLS and NES-GFP2-M9. The zinc finger transcription factor EZI is 













p-values (n/ n) 
TERT-GFP, Mock/KD IPO7 <0,002 
NES-GFP2-NLS, Mock/KD IPOβ <0,02 
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The artificial import substrate NES-GFP2-NLS is recognized by importin-β and was used here as 
a control to visualize the effect of the importin-β knock down. In contrast, NES-GFP2-M9 is 
imported by transportin. The substrate was used as a control for transportin knock down and 
also to quantify the efficiency of the knock-down. For importin-9 no control plasmid was 
available. The efficiency of importin-β /-7 /-9 knock-downs was controlled by Western blot 
(figure 15 B). 
Under mock conditions, TERT-GFP, the artificial import substrates and EZI all localized to the 
nucleus (figure 14 A/B). Depletion of importin-9 did not affect the localization of any reporter 
protein. Also TERT-GFP was not affected in its nuclear localization, suggesting that importin-9 
is not involved in its import (Figure 14 A/B).  
Depletion of importin-β also did not lead to a significant mislocalization of TERT-GFP. EZI and 
NES-GFP2-M9 were also not affected by importin-β depletion. The importin-β dependent 
substrate NES-GFP2-NLS predominantly localized either to the cytoplasm or was distributed 
equally throughout the cell (figure 14 A/B).  
The transportin knock-down resulted in a cytoplasmic or equal distribution of the reporter 
NES-GFP2-M9, showing that the knock-down was efficient (figure 14 A/B). TERT-GFP was not 
affected by the knock-down, suggesting that also transportin is not the import receptor of 
TERT. Also the localization of EZI and NES-GFP2-NLS did not change. 
By contrast, the importin-7 knock down showed a clear effect on TERT-GFP localization. The 
protein was localized either in the cytoplasm or was distributed homogenously throughout 
the whole cell (figure 14 A/B). Also the positive control EZI localized to the cytoplasm in the 
importin-7 knock down. This result suggested that importin-7 serves as an import receptor for  
TERT. Importin-7 also seems to act independently from importin-β as import receptor of 
TERT-GFP. Another siRNA against importin-7 (siRNA importin-7-1), targeting the importin-7 
mRNA at a more downstream site was tested to confirm the results (figure S2). This siRNA 
also led to the already described import defects on TERT-GFP. The C-terminus of TERT (aa 
601-1132) also responded to the depletion of importin-7 and resulted in a decrease of 
nuclear localization. 
As a second approach and to confirm the results of the siRNA experiments, an 
immunoprecipitation (IP) using the GFP-nanotrap was performed. HEK-293T cells were 
transiently transfected with TERT-GFP or with GFP as a control. GFP-tagged proteins were 
precipitated and samples were subjected to SDS-PAGE and Western blotting.  
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Figure 15: Immunoprecipitation of TERT-GFP and TERT mutants 
(A) Immunoprecipitation (IP) from TERT-GFP and TERT-NLS mutants using the GFP-nanotrap. 293T cells were 
transiently transfected with TERT-GFP or TERT NLS mutants or GFP alone serving as a control. Cells were lysed 
and subjected to the IP. Inputs were taken from the lysate to confirm expression rate and full length protein 
expression. First, the TERT bait proteins (151kDa) and the control protein GFP (26kDa) were detected using a 
rabbit α-GFP antibody to confirm its size and expression. Both proteins were detectable in the input as well as 
in the IP on the membrane. Red asterisks mark the band resulting from TERT proteins while the green asterisks 
show GFP. (B) Western blot control of knock down efficiency for importin-9, importin-β and importin-7 using 
the respective antibodies. Tubulin was detected as a loading control. 
 
If TERT interacts with an import receptor, the respective receptor should also be detectable 
on the membrane. Therefore, the blot was probed with antibodies against different import 
receptors. As shown on the blot TERT-GFP was efficiently precipitated in the IP (figure 15 A). 
In the IP importin-β did not coprecipitate, indicating that importin-β is either not an import 
receptor of TERT or not able to bind under the IP conditions. However, binding of importin-7 
(119 kDa) to TERT-GFP was detectable (figure 15 A).  
In the control lane of precipitated GFP, no importin-7 was detectable, suggesting that 
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TERT. Other transport factors tested e.g. importin-9 or CRM1 either did not significantly bind 
in the IP or bound unspecifically to the GFP control (data not shown). 
The NLS mutants of TERT were also tested for importin-7 binding (figure 15 A) to investigate 
whether importin-7 uses these NLS sites for import of TERT. The IP showed that importin-7 
also bound to the mutants (figure 15 A ), suggesting that importin-7 either might not bind the 
identified NLS motifs or is sticky on TERT under the given IP conditions. Another explanation 
for the coprecipitation of importin-7 with the mutants could be residual binding of importin-7 
to the mutants at the residing intact residues of the NLSs. However, depletion of different 





4.2.7 Localization of TERT-GFP can be rescued by importin-7 overexpression after depletion of 
endogenous importin-7 
To confirm the specificity of the TERT-GFP import defects after importin-7 knock down, 
rescue experiments with siRNA resistant importin-7 were carried out. For that purpose, 
Xenopus laevis importin-7, which is 96% homologous to human importin-7 was used. Xenopus 
importin-7 already carried a base substitution compared to human importin-7 at the siRNA 
target site. Two further silent base substitutions were introduced by site directed 
mutagenesis to achieve siRNA resistance. HeLa cells were treated with importin-7 siRNA for 
72 hours and were then transfected with plasmids as mentioned below. Control cells (mock) 
were transfected with a scrambled non-targeting siRNA. Knock down efficiency of importin-7 
was confirmed by Western blotting (figure 16C). EZI was again used as a positive control for 
importin-7 knock-down and for the rescue experiment to demonstrate the functionality of 
overexpressed importin-7-HA.  
In mock cells, and in presence of overexpressed importin-7-HA, EZI and TERT-GFP localized to 
the nucleus exclusively as seen in previous experiments. Upon importin-7 knock down, TERT-
GFP and EZI showed a clear import defect resulting in a predominantly cytoplasmic 
localization or an equal distribution of EZI or TERT-GFP, respectively (figure 16A/B). Only 
35.5% of the cells transfected with EZI showed a nuclear localization of EZI and 32% of the 
analyzed cells showed a nuclear accumulation of TERT-GFP. 
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Figure 16: TERT-GFP import defects by importin-7 knock down can be rescued by importin-7 overexpression 
(A) HeLa cells were incubated with importin-7 siRNA for 72 hours and were then transiently transfected with 
TERT-GFP or myc-EZI plasmid DNA. For rescuing the importin-7 import defect, cells were cotransfeced with a 
siRNA resistant importin-7-HA plasmid. Cells were then subjected to immunofluorescence. Myc-EZI was 
detected using a mouse α myc antibody while Ha-Importin7 was detected by using a mouse α Ha antibody. (B) 
Quantification of transfected cells. TERT-GFP mock was quantified by counting 100 cells from 14 independent 
experiments. TERT-GFP importin-7 knock down was analyzed using counts from 11 independent experiments 
with 100 cells each. The remaining conditions were quantified by counting 100 cells from three independent 
experiments each. Error bars show the standard deviation from the mean of the experiments. For confirmation 
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The import defect of both overexpressed proteins could be rescued by overexpression of 
siRNA resistant importin-7-HA significantly (figure 16A/B). After cotransfection with the 
importin-7 siRNA resistant importin-7-HA plasmid an average of 47.5% of the analyzed cells 
showed a rescue effect resulting in 83% of cells in which a nuclear accumulation of EZI was 
observed. For TERT-GFP nuclear accumulation of the protein could be detected in 74% of cells 
after cotransfection with importin-7-HA, resulting in a rescue effect of 42% after 
overexpression of siRNA resistant importin-7-HA (figure 16B). This experiment validated the 
previous experiments showing that Importin7 plays a key role in TERT-GFP import, because 
the knock down effect can be reversed by overexpression of importin-7.  
The import defect of endogenous TERT after depletion of importin-7 could not be tested in 




4.2.8 In vivo analysis of import inhibition after importin-7 knock down 
To demonstrate that import intensity of TERT-GFP was negatively influenced by depletion of 
importin-7 compared to mock cells, live cell FLIP was performed to measure transport 
kinetics. For this FLIP experiment, the same settings were used as described before in 3.5.2. 
HeLa cells were either treated with importin-7 siRNA or a scrambled non-targeting siRNA as a 
control. Following siRNA treatment, cells were transfected with a plasmid coding for TERT-
GFP. Knock down efficiency was confirmed by Western blotting (figure 17B). TERT-GFP 
transfected live cells were bleached in the nucleus and the import rate was determined by the 
loss of fluorescence in the cytoplasm. As shown in figure 17A, import of TERT-GFP can be 
inhibited by depletion of importin-7. Under mock conditions, it took 94.7 seconds until a loss 
of fluorescence of 50% could be observed. When importin-7 was depleted a loss of 
fluorescence of only 34.7% could be observed after 146 seconds at the end of the 
measurement. These measurements showed that under mock conditions, TERT-GFP is 
imported quickly and its import is significantly reduced when importin-7 is depleted, 
suggesting that importin-7 is the import receptor of TERT.  
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Figure 17: Import inhibition on TERT-GFP after depletion of importin-7 can be demonstrated in living cells 
(A) HeLa cells were treated with a siRNA against importin-7 or a scrambled non-targeting siRNA (mock) and 
incubated for 72 hours. Cells were then transiently transfected with TERT-GFP plasmid DNA. The assay was 
performed in three independent experiments and 10-15 cells were analyzed per condition. Error bars in the 
diagram were left out for better clarity (the standard deviation is shown in figure S12). Instead, the mean 
values of measured cells are shown. Asterisks in the images indicates the bleached region in the nucleus. The 
red arrow marks the darkened cytoplasm of the bleached control cell after 146 seconds compared to the 
beginning of the measurement. The arrowhead points at the relatively bright cytoplasm of an Importin7 knock 
down cell after 146 seconds compared to the start of the analysis. In order to gain comparable data, cells with 
equal levels of fluorescence in their cytoplasm in mock as well in KD cells were chosen (figure S8). (B) Knock 
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4.2.9 Importin-7 can bind to Nup358 in a RanGTP dependant manner 
Since previous experiments showed a dependency of TERT-GFP import on Nup358 and 
importin-7, it was interesting to investigate the relationship between importin-7 and the 
nucleoporin. Nup358 exhibits a number of FG-repeats within its structure which might 
interact with transport receptors such as importin-β (Delphin et al., 1997). Like Nup358, the 
import receptor importin-7 contains Ran binding sites (Görlich et al., 1997) which both 
proteins could use for interaction. To investigate the mechanism of putative interactions 
between Nup358 and importin-7, immunoprecipitations and in vitro binding assays were 
performed. 
First the in vivo context was investigated. Native full length Nup358, was immunoprecipitated 
from a HeLa cell lysate using a goat α Nup358 antibody. The first sample was wasged with IP-
washing buffer, only (sample 1), showing the native binding partners of the nucleoporin 
under IP conditions. As shown in figure 18A, importin-β clearly bound to Nup358 under native 
conditions, supporting the idea that it used the nucleoporin FG repeats for binding (Delphin et 
al., 1997). In contrast, importin-7 was not detectable under these conditions. The binding of 
importin-β to Nup358 could lead to a competitive situation on the nucleoporin for other 
importins that have weaker affinities towards Nup358. Therefore, the amount of bound 
importin-β to the nucleoporin was reduced by the addition of 500mM NaCl to the IP-washing 
buffer (samples 2 and 3). Afterwards, recombinant importin-7 was added to the beads in the 
presence or absence of GTP loaded RanQ69L. This Ran mutant cannot hydrolyze its bound 
GTP (Nachury et al., 1999). 
However, reduction of bound importin-β alone to Nup358 did not lead to a binding of 
importin-7 to the nucleoporin as shown in sample 2. This finding suggested that if importin-7 
binding to Nup358 occurs, it requires additional factors. Finally, the addition of RanQ69L lead 
to a binding of importin-7 to Nup358, suggesting that importin-7 does not interact with 
Nup358 through FG binding but uses the cofactor Ran for interaction with the nucleoporin. 
To further investigate this interaction, a recombinant in vitro binding assay was performed. 
Recombinantly expressed GST-tagged Nup fragments (figure 18C) were coupled to GST-beads 
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Figure 18: importin-7 binds to recombinant Nup358 fragments and to endogenous Nup358 in a RanGTP 
dependant manner. 
(A) Untransfected HeLa cells were used for an immunoprecipitation (IP) of Nup358 using a specific goat α 
Nup358 antibody. The total IP volume was split into three samples each of the same volume represented by 
lanes 1-3. Lane 1 contained the native IP with Nup358 showing its binding partner importin-β. Endogenous 
importin-7 did not bind to Nup358 under these IP conditions. Samples 2 and 3 were washed with dilution 
buffer containing 500mM NaCl reducing the amount of bound importin-β on Nup358. Samples 2 and 3 were 
then incubated with 2µg of recombinant His-importin-7 while sample 3 was additionally incubated with 1µg of 
GTP loaded RanQ69L. To ensure specific binding to Nup358 a protein-G control was carried out using a HeLa 
cell lysate.  (B) Coomassie gel of an in vitro binding assay of recombinant Nup358 fragments and importin-7 
showing dependence on RanGTP. 5µg of each GST-Nup358 fragment was coupled to GST-beads and incubated 
with 5µg His-importin-7 +/-2µg RanQ69L loaded with GTP. GST was used as a control for specific importin-7 
binding.  (C) Schematic description of Nup358 and its recombinant GST-tagged truncation mutants used in (A). 
 
As shown in figure 18B, importin-7 binding to Nup fragments only occurred in those 
fragments containing a Ran-binding site and in the presence of RanQ69L. In contrast, 
fragments containing only FG repeats as a putative binding site for importin-7 were not able 
to bind importin-7 (figure 18B). This could indicate that importin-7 might not use FG repeats 
to bind to the nucleoporin. Instead, as also demonstrated in the immunoprecipitation, the 
interaction seemed to be Ran dependent, suggesting that both proteins interact with each 
other via Ran.  
It could be conceivable, that Importin-7 binding to Nup358 is not generally required for the 
import of the receptor and its cargo. Our findings rather support previous findings that import 
receptors such as transportin and importin-β complex with RanGTP to release their cargoes 
and to be exported from the nucleus into the cytoplasm by interaction with the NPC (Jäkel et 
al., 1998; Izaurralde et al., 1997; Görlich et al., 1997).  
However, the release mechanism of importin-7 from TERT-GFP must differ from this known 
pathway. Experiments with RanQ69L addition after TERT-GFP immunoprecipitation did not 
show a dissociation of importin-7 from TERT-GFP (figure S9) suggesting an alternative 




4.2.10 TERT-GFP import inhibition can be enhanced by co-depletion of importin-7 and Nup358 
Our result described so far showed that, depletion of Nup358 as well as depletion of the 
importin-7 negatively affect nuclear localization of TERT-GFP. To further analyze whether 
import inhibition on TERT-GFP can be enhanced by simultaneous depletion of importin-7 and  
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Figure 19: TERT-GFP import inhibition can be enhanced by co-depletion of importin-7 and Nup358 
(A) HeLa cells were incubated with either siRNA against importin-7 or a scrambled non-targeting siRNA as a 
control for 72 hours. Cells were then transiently transfected with following plasmid DNA: TERT-GFP, TERT 236 
KR-AA-GFP, myc-EZI or the artificial shuttle substrate NES-GFP2-NLS. Cells were subjected to 
immunofluorescence and EZI was detected by using a mouse α myc antibody. HeLa cells were used to perform 
a knock-down against Nup358. KD efficiency was controlled by immunofluorescence, analyzing only cells with a 
significantly reduced level of Nup358. Double knock down of Nup358 and importin-7 was performed similarly, 
starting with incubation of siRNA against Nup358 for 48 hours followed by a retransfection of siRNA against 
Nup358 containing also the siRNA against importin-7. Cells were then incubated for 72 hours to ensure the 
reduction of importin-7 protein level. Knock down cells were then transiently transfected with plasmid DNA 
mentioned above. (B) Quantifiation of cells mentioned in (B). Quantification was carried out by counting at 
least 100 cells for each condition from three independent experiments. For quantification of TERT-GFP (mock) 
counts from 14 experiments were used and after KD of importin-7 counts from 11 experiments were used. 
Values of the colored bars represent mean values while the error bars represent the standard deviations. (C) 
Western blot control after importin-7 siRNA treatment and double knock down of importin-7 and Nup358. 
Tubulin served as a loading control. 
 
 
Nup358, a double knock down of both proteins was performed. Effects of the double knock 
down were then compared to single knock downs done and to control cells (mock). In mock 
cells, NES-GFP2-NLS, EZI and TERT-GFP predominantly localized to the nucleus. The import 
defective mutant TERT 236 KR-AA-GFP showed a predominantly equal distribution between 
cytoplasm and nucleus (figure 19 A/B). The NLS mutant was used here to investigate if also 
import defective TERT is still dependent on NUP358.  
Knock down of importin-7 resulted in a massive decrease of nuclear accumulation of EZI and 
TERT-GFP as described above (figure 19 A/B). The import defective mutant of TERT-GFP, TERT 
236 KR-AA-GFP resulted in a much greater cytoplasmic localization, when importin-7 was 
depleted as compared to mock conditions (figure 19 A/B). The artificial shuttle NES-GFP2-NLS 
remained unaltered in its localization within the importin-7 knock down showing that 
importin α/-β mediated import remained unaffected by importin-7 depletion (figure 19A). 
Single knock down of Nup358 resulted in less nuclear accumulation of TERT-GFP as described 
before (see figure 13). The import defective mutant also resulted in increased cytoplasmic 
localization. Interestingly, the localization of EZI was not affected by Nup358 depletion (figure 
19 A/B), suggesting that defects in protein nuclear accumulation following Nup358 depletion 
is specific for TERT or other Nup358-dependent proteins and does not affect all proteins 
imported by importin-7 in general.  
Previous work showed a dependency of importin-α/-β mediated transport on Nup358 (Hutten 
et al., 2008). In cells depleted of Nup358 an impaired import of the artificial importin-α/-β 
dependent import substrate NES-GFP2-cNLS was detected (Wälde 2010; Hutten et al., 2008). 
4) Results  




In contrast to these previous findings a strong dependency of the artificial import substrate 
NES-GFP2-cNLS on Nup358 could not be detected in this work. Only a slight reduction of 
nuclear accumulation of NES-GFP2-cNLS after depletion of Nup358 of about 15-20% could be 
observed. This might be due to a different charge of HeLap4 cells used in this work compared 
to previous work or resulted from different KD efficiencies of Nup358. 
Double knock down of the import receptor importin-7 and Nup358 resulted in an enhanced 
cytoplasmic localization of TERT-GFP, showing that the import defect was enhanced when 
both factors involved in TERT-GFP import are depleted. Corresponding to the importin-7 
knock down, EZI showed a reduction of only 34% in nuclear accumulation (figure 19 B). This 
could be explained by a weaker effect of the importin-7 siRNA during simultaneous 
performance of a knock-down against two proteins. 
Taken together, these results show that import of TERT-GFP depends on the presence of 
both, importin-7 and Nup358. These results also show that depletion of Nup358 seemed not 
to influence importin-7 mediated import in general and that the nucleoporin is not rate 


















The prostaglandin 15d-PGJ2 inhibits CRM1 mediated protein export 
Leptomycin B is a highly specific, inhibitor for CRM1 mediated protein export, produced by 
the fungus Streptomyces. It binds to a sensitive cysteine residue (at aa position 528 in the 
human sequence) (Kudo et al., 1999). LMB contains a reactive ring with a free electron pair 
connected to a fatty acid tail (figure 4A). In light of the strong inhibition of nuclear export that 
can be obtained with LMB as an exogenous substance, it was interesting to investigate 
putative endogenous factors which could potentially be produced by the eukaryotic cell itself. 
The prostaglandin 15d-PGJ2 was a promising candidate since it has a similar structure to LMB. 
In this work, we investigated the ability of 15d-PGJ2 to impair CRM1 mediated protein export 
and we were able to identify CRM1 as one of several targets of 15d-PGJ2. 
 
 
Accumulation of the prostaglandin 15d-PGJ2 in the nucleus 
Prostaglandins normally bind to specific transmembrane receptors at the plasma membrane, 
but it is known for 15d-PGJ2 that it can cross the cell membrane to act intracellular (reviewed 
in Scher et al., 2009). Although import pathways of 15d-PGJ2 through plasma membranes still 
remain unclear (reviewed in Scher et al., 2009) we were able to show that biotinylated 15d-
PGJ2 can enter the cell. This means that the prostaglandin has to cross the plasma membrane. 
It might be conceivable that 15d-PGJ2 diffuses through the plasma membrane. As a 
membrane derivative, 15d-PGJ2 contains a fatty acid tail which could be used to be integrated 
into the membrane and to cross it by diffusion until the prostaglandin reaches the cytoplasm. 
The biotinylated 15d-PGJ2 used in this work translocates to the nucleus and accumulates 
there. The prostaglandin therefore either diffuses passively through the nuclear pore or 
targets proteins that accumulate in the nucleus, for example transport factors or their 
substrates. Our data also show that biotinylated 15d-PGJ2 accumulates in the nucleus after 
only a short incubation time, suggesting that after translocation to the nucleus the 
prostaglandin is retained there, which leads to the hypothesis that 15d-PGJ2 specifically 
targets nuclear proteins (figure 1). A binding approach using biotinylated 15d-PGJ2 with cell 
lysate identified several nuclear proteins and CRM1 as targets of 15d-PGJ2 (data not shown).  





It is also known that the prostaglandin also targets and modifies the nuclear protein and 
transcription factor PPARγ. After modification, the 15d-PGJ2/PPARγ complex translocates into 
the nucleus (reviewed in Scher et al., 2004). 15d-PGJ2 has also other targets like the IκB  
kinase (Straus et al., 2000; Rossi et al., 2000) or the HIV transactivating protein Tat, (Kalantari 
et al., 2009) and it also targets cysteine 184 in the GTP-binding protein H-Ras (Oliva et al., 
2003). It is therefore likely that many other proteins including nuclear proteins are also 15d-
PGJ2 targets, which could explain the strong nuclear accumulation of the prostaglandin.  
It remained unclear whether CRM1 is also retained in the nucleus during the time of export 
blockade, or whether the blocked CRM1 is also able to leave the nucleus without a cargo.  
A reduced ability for export after 15d-PGJ2 modification of the main export factor CRM1 
might contribute to retention of other putative 15d-PGJ2 targets in the nucleus. Proteins to be 
exported to the cytoplasm are kept in the nucleus and might bind to other proteins and form 
complexes that might not occur without an inhibition of their export factor CRM1, thus 
enhancing nuclear accumulation of the prostaglandin by providing potentially new targets. 
Previous studies detected several CRM1 specific inhibitors, but all of the discovered CRM1 
inhibitors such as LMB are exogenous substances (Sun et al., 2013). In contrast, 15d-PGJ2 is an 
endogenous product of higher eukaryotic cells and has the ability to regulate CRM1 mediated 
protein export as an endogenous inhibitor (Hilliard et al., 2010). 
 
 
Several CRM1 substrates show different sensitivities towards CRM1 export inhibition by 15d-
PGJ2  
We were able to identify CRM1 as a target of 15d-PGJ2 in vitro by mass spectrometry. We 
were also able to show that 15d-PGJ2 is capable to inhibit CRM1 mediated protein export. 
Export of CRM1 specific substrates to the cytoplasm e.g. the reporter proteins NES-GFP2-
cNLS/ -M9 or NC2β can be inhibited after incubation with 15d-PGJ2, as demonstrated in 
quantification analysis and in living cells, as indicated by the FLIP experiments. Rescue 
experiments, using the LMB resistant CRM1 mutant C528S showed that 15d-PGJ2 can indeed 
modify wild type CRM1 at this sensitive cysteine and therefore blocks its export function. 
CRM1 C528S was able to export its substrates after incubation of 15d-PGJ2, suggesting that 
the mutant is resistant towards 15d-PGJ2 modification (figure 8). 





Our data showed that not all CRM1 substrates were inhibited equally. The CRM1 substrate 
TFIIAα for example could be retained in the nucleus only after application of high levels of 
15d-PGJ2. In contrast, the export of the CRM1 substrate NC2β could be inhibited at 
nanomolar concentrations of the prostaglandin (figure 6). This could be due to different 
affinities of the substrates for CRM1. For NC2β it was suggested that it exhibits a low affinity 
towards CRM1 (Kahle et al., 2009). The level of export inhibition could also depend on the 
position where the substrate binds within the NES binding groove of CRM1. For the CRM1 
export substrate snurportin1 it could be shown that it uses more than one binding site in the 
CRM1 molecule (Monecke et al., 2009). It is therefore likely that different substrates use 
different binding sites within the CRM1 molecule. Although CRM1 export substrates bind at 
the NES binding groove in the hydrophobic cleft, they can possess different affinities in CRM1 
binding which can influence the inhibitory effect of 15d-PGJ2 on CRM1 mediated protein 
export. This could help to explain different behaviors of CRM1 substrates towards CRM1 
inhibition by 15d-PGJ2. Another explanation for reduced inhibitory effect of 15d-PGJ2 could be 
the difference in structure of LMB and 15d-PGJ2. LMB contains a longer carbon-rich tail than 
15d-PGJ2. This could help to inhibit CRM1 mediated protein export more efficiently than this 
could be achieved by 15d-PGJ2, which exhibits a much shorter tail. LMB occupies 70% of the 
NES binding groove and therefore blocks the interaction of NES with CRM1 very strongly (Sun 
et al., 2013). The structure of bound 15d-PGJ2 to CRM1 has not been solved yet. The fungal 
CRM1 inhibitor also helps to open and deepen the CRM1 NES binding groove by interaction. 
Interestingly, CRM1 was also found to enhance lactone hydrolysis of LMB by conformational 
changes of other residues and therefore drives modification by itself (Sun et al., 2013). This 
mechanism can contribute to the high potency of LMB as a CRM1 inhibitor and to the low 
concentrations needed of LMB to inhibit CRM1 mediated protein export effectively. For 15d-
PGJ2 none of these supporting mechanisms could be shown yet. 
It also remains unclear how efficiently extracellular added 15d-PGJ2 enters the cell or even 
the nucleus, since its import pathways into the cells and also the amount of imported 15d-
PGJ2 after extracellular addition remains unclear (Hilliard et al., 2010). Unbound 
endogenously produced 15d-PGJ2 could be detected in a concentration of 16 nanomolar in a 
cell lysate (Rajakaria et al., 2007), but 15d-PGJ2 which was already bound to targets could not 
be included in the measurement (Hilliard et al., 2010). Phospholipase A2, the arachidonic 
releasing enzyme as well as PGHS, which processes arachidonic acids to PGH2, a precursor 





prostaglandin of 15d-PGJ2 were detected at both nuclear membranes (Spencer et al., 1998; 
Perisic et al., 1999). It is therefore likely, that bioactive concentrations of 15d-PGJ2 can be 
much higher at the cytoplasmic periphery of the nucleus to modify CRM1 and inhibit its 
nuclear protein export. 
Also, in contrast to LMB which is a highly specific target of CRM1, 15d-PGJ2 has more than one 
target in the cell. It is known that besides CRM1 the prostaglandin can target several other 
proteins such as BSA, IκB kinase and PPARγ (Straus et al., 2000; Rossi et al., 2000). This can 
also explain why higher initial concentrations of 15d-PGJ2 are needed to visualize its inhibitory 
effect on CRM1 mediated protein export.  
This study showed that at least one additional prostaglandin in addition to 15d-PGJ2 has the 
ability to inhibit CRM1 mediated protein export besides 15d-PGJ2. PGA for example contains a 
cyclopentenone ring with a free reactive group and was also shown to have a certain 
potential to inhibit CRM1 mediated protein export (figure 4 A/B). Apart from 15d-PGJ2 and 
PGA other prostaglandins also exist which contain a cyclopentenone ring containing a free 
electron pair. During an inflammation, cells of inflammatory response produce a subset of 
prostaglandins and a certain number of those have a reactive cyclopentenone ring. In this 
situation, CRM1 could be targeted by other prostaglandins similar to 15d-PGJ2. This could 
then lead to a stronger inhibition of CRM1 mediated protein export by endogenously 
produced prostaglandins than shown in this work where only single prostaglandins were 
incubated with the cells.  
15d-PGJ2 can be processed from precursor prostaglandins within the cell, while other 
prostaglandins first need extracellular receptors to influence the cell. It can therefore act as 
an intracellular and as an extracellular prostaglandin (Scher et al., 2004). 
Taken together, these results show that the inhibitory effect on CRM1 mediated export could 
endogenously be enhanced by the cooperative action of several cyclopentenone 
prostaglandins. We found that 15d-PGJ2 has the ability to inhibit CRM1 mediated nuclear 
protein export, although a higher concentration, extracellularly added, is required to see the 
same effects as with LMB. Genes that are CRM1 dependently expressed may also be 
influenced by the inhibition of CRM1 mediated export. Regarding this aspect, also little 
changes in CRM1 activity mediated by endogenous as also exogenous 15d-PGJ2 might have 
severe effects on cellular functions (Hilliard et al., 2010). 
 





15d-PGJ2 has anti-inflammatory effects 
Modification of CRM1 by 15d-PGJ2 and the resulting inhibition of CRM1 mediated protein 
export might contribute to its anti-inflammatory effects. During the cell cycle many different 
proteins are imported into the nucleus. Many of them are also exported again by CRM1. 
Transcription factors, for example are exported when their function is not required any more. 
In the case of an export blockade all these proteins are retained in the nucleus and might 
contribute to damaging effects on the cell. Long-term CRM1 export blockade with LMB at a 
CRM1 saturating concentration prevents cells from dividing and induces apoptosis (Mutka et 
al, 2009).  
15d-PGJ2 with its inhibitory effect on CRM1, can in the same way contribute to cell cycle 
arrest and later on enhance cell death or apoptosis (Shin et al., 2009). The inhibition of CRM1 
mediated protein export marks a negative influence on pathways in cells and may change cell 
fate dramatically. This can also contribute to the previously described anti-inflammatory 
effect of 15d-PGJ2. 
For the highly specific CRM1 inhibitor LMB it was reported that it is a potent anti-cancer drug 
in cell culture (Mutka et al., 2009; Shao et al. 2011). However, the high toxicity of LMB 
prevents it from being used as such. For 15d-PGJ2 an anti-cancer activity was reported in a 
study that showed induction of apoptosis in leukemia and colorectal cancer cells (Shin et al., 
2009). It therefore may be that in this case the inhibition of CRM1 mediated export in fast 





The inhibitory effect of 15d-PGJ2 on CRM1 mediated export could be shown in this work only 
after application of exogenous 15d-PGJ2. It would be interesting to investigate whether 
endogenous 15d-PGJ2 would have the same effect. It also remained unclear how much of 
endogenously produced 15d-PGJ2 is needed to show comparable effects. The strength of 
export inhibition on different CRM1 substrates varied a lot during this work. There are 
substrates such as NC2β whose export can be inhibited efficiently following application of low 
levels of 15d-PGJ2. In contrast, only physiologically irrelevant concentrations of the 
prostaglandin lead to export inhibition of certain CRM1 substrates e.g. RanBP1. Therefore, 





further studies on structural changes within the CRM1 molecule, especially in the NES binding 
site after 15d-PGJ2 modification are essential. Following the example of LMB-studies (Sun et 
al., 2013), precise studies about binding mechanisms of 15d-PGJ2 at the cysteine 528 in the 
CRM1 molecule have to be performed. To better understand the mechanisms of export 
inhibition it needs to be revealed which conformational changes the export factor undergoes 



























Import of Human TERT import depends on importin-7 and a zinc finger region in 
Nup358 
 
Human TERT localizes to the nucleus 
Endogenous TERT as well as overexpressed TERT localize to the nucleus (Wong et al., 2002). 
In this work overexpressed GFP-tagged human TERT showed an intranuclear homogenous 
localization. TERT is a 126 kDa protein (Mitchell et al., 1999; Harley et al., 1990) which is too 
large to translocate through the nuclear pore and enter the nucleus by diffusion alone, it 
needs to be actively transported.  
Very few details about transport of the TERT protein were known. The best studied transport 
direction of human TERT is export which is described to be mediated by CRM1 and also 
triggered by oxidative stress via Src kinase family-dependent phosphorylation of tyrosine 707 
(Seimiya et al., 2000; Haendeler et al., 2003). Import pathways and receptors involved in TERT 
nuclear import remained unknown, so far. It was reported that the interaction of 14-3-3 
proteins with the C-terminus of TERT is required for nuclear import of the protein (Seimiya et 
al., 2000). 
TERT is involved in ageing and its expression is upregulated in many cancer cells, suggesting a 
role in cancer development and progression (Mitchell et al., 1999; Harley et al., 1990). It is 




Fragments of TERT localize to the nucleus 
To investigate which region of TERT is responsible for the import of the protein, several 
regions have been cloned into GFP fusion vectors. However, as shown in this work, cloned 
fragments of TERT always localized to the nucleus although no NLS motifs were detected in 
the respective sequences. It is possible that in every cloned N-terminal TERT fragment an 
unknown NLS motif could be hidden, but perhaps the fragments could rather bind to 
secondary proteins to be transported into the nucleus.  
Those proteins that complex with TERT later in the nucleus, especially the N-terminal and TR 
binding H/ACA proteins dyskerin, NOP10, NHP2 which complex in the cytoplasm (reviewed in 





Hukezalie et al., 2013), could bind especially the short TRBD (telomerase-RNA- binding-
domain) containing fragment and translocate it to the nucleus. Due to their truncation, N-
terminal TERT fragments could also be disrupted in their structure compared to the full length 
protein. It might be conceivable that certain regions are ectopically exposed to the surface of 
the N-terminal fragments which would be hidden in full length context, attracting import 
receptors to transport the mutants into the nucleus. 
Another explanation for the nuclear localization of the fragments could be that the N-terminal 
fragments bind to other truncated TERT molecules. It is unknown how much and at which 
concentration different truncated TERT proteins are present in a cell. Assembly and 
complementation studies suggested that the RID1 (also called TEN domain) containing N-
terminal part of human TERT can interact with truncated parts of TERT containing RID2-RT-
CTE domain (reviewed in Autexier et al., 2006). These observations also fit to our findings that 
most of the tested cloned fragments of TERT localized to the nucleus, therefore this study 
was continued using full-length TERT only. 
 
 
Importin-7 is an import receptor of human TERT 
In vivo FLIP experiments demonstrated an influence of importin-7 in TERT import kinetics, as 
import rate of TERT decreased significantly after importin-7 knock-down compared to control 
cells (figure 17). Additionally, knock-down experiments with siRNAs for major import 
receptors like importin-β, transportin and importin-9, revealed that only importin-7 depletion 
had a major impact on the localization of TERT (figure 14). 
Although we cannot completely exclude the involvement of other import factors on nuclear 
import of TERT since we tested only a subset of available import receptors in a cell, we can 
demonstrate a strong and specific role for importin-7 in TERTs nuclear import. Rescue 
experiments based on a siRNA resistant importin-7 construct showed that importin-7 
overexpression can indeed specifically rescue TERTs nuclear localization after depletion of its 
import receptor importin-7 (figure 14). Taken together, these findings demonstrate a 
significant role for importin-7 in nuclear import of TERT. 
After import into the nucleus the substrate has to be released from its import receptor. This 
usually is achieved by binding of RanGTP to the import receptor. In this work the cargo 
release by RanGTP from importin-7 was also tested (figure S9). Release of importin-7 from 





TERT could not be achieved by addition of RanQ69L, suggesting that TERT-importin-7 
interaction in the nucleus is disrupted by either an unknown nuclear factor or by higher 
affinity of TERT towards other nuclear components. The resistance of importin-7 cargos to 
their release from the receptor by RanGTP was described previously. For example, the 
ribosomal protein rpL23a cannot be completely released from importin-7 by RanGTP (Jäkel et 
al., 1998). The author mentioned a 30 fold lower affinity of importin-7 for RanGTP, compared 
to importin-β, as a possible reason for this finding (Jäkel et al., 1998). The same effect could 
also be shown for the substrates c-Jun and HIV-1 Rev which are imported by multiple import 
receptors via an arginine rich sequence (Waldmann et al., 2007; Arnold et al., 2006). The 
addition of RanQ69L led to a significant disassembly of importin-substrate complexes with the 
exception of importin-7, which was obviously resistant towards RanQ69L addition and still 
bound its substrate. 
For histone H1, which is imported by an importin-β- importin-7 heterodimer, it was shown 
that RanGTP is required for its import to finally complete NPC passage and to induce the 
release of importin-β at the terminal transport step at the nuclear pore (Jäkel et al., 1999). 
But experimental data led to the suggestion that the H1- importin-7 complex still exists in the 
nucleus. RanGTP than later aids the histone transfer from importin-7 to the DNA where H1 is 
incorporated into chromatin (Jäkel et al., 1999).   
It could therefore be that TERT dissociation from importin-7 can also be facilitated by 
interaction of RanGTP with the import receptor. Due to the reduced affinity of RanGTP 
towards importin-7, other factors with a higher affinity towards TERT than importin-7 might 
be required to completely dissolve this cargo-receptor complex. These factors might be 
nucleolar proteins e.g. nucleolar transport factors. It is known that TERT can also be found in 
nucleoli (Tomlinson et al., 2006). Telomeric proteins such as TPP1 and TIN2 which recruit 
telomerase to the telomeres (reviewed in Egan et al., 2012) could also help RanGTP to 
dissolve the import complex. 
A previous study mentioned CRM1 as the export factor of TERT (Seimiya et al., 2000). In our 
study FLIP experiments with and without LMB indicated that export of TERT in general does 
not occur at a fast rate (figure S7). Incubation of TERT and TERT NLS mutants transfected cells 
with LMB also did not change localization of the relevant proteins much (Chung et al., 2012), 
indicating that also here TERT is not exported with a high rate. 
 





TERTs NLS motifs and their role in import  
A motive scan of the protein sequence of human TERT indicated the existence of a putative 
NLS motif at position 236-240 (KRPRR). Following mutation of the amino acids KR to alanines 
(TERT KR 236/237 AA-GFP) TERT showed a homogenous distribution all over the cell, or 
localized to the cytoplasm, indicating the existence of a functional NLS. This NLS site was also 
shown independently from this work by Chung et al., 2012. The still high percentage of cells 
(60%) showing an equal distribution of overexpressed TERT KR 236/237 AA-GFP in this work, 
suggested the existence of at least one additional NLS motif or a larger importin binding site 
in the protein sequence of the telomerase protein. It is also possible that TERT complexes 
with other proteins which drive the import of TERT into the nucleus or that residual binding of 
the import receptor at the two intact residues (aa at position 239/240) occurs.  
Also Chung et al., 2012 reported that ~ 30% of the analyzed cells still show a non-cytoplasmic 
localization of a mutant whose NLS is completely mutated (236-KRPRR-240        236-AAPAA-
240), indicating that also in their work either a yet unidentified NLS or a TERT interacting 
protein promotes import of TERT. 
We showed the KR motif in the NLS is necessary for import. Thus, we started to search for 
other existing KR motifs within the protein. However, around 40% of the analyzed cells 
expressing the double mutant TERT KR 236/237 AA; KR 649/650 AA-GFP still showed a 
homogenous localization of the protein throughout the cell (figure 11), suggesting that TERT 
has additional unknown NLS motifs or importin binding regions.  
Our data identified importin-7 as an import receptor for human TERT. The question arose 
whether importin-7 binds to the identified NLSs. It could be conceivable that importin-7 binds 
to the already identified NLS sites in the protein and therefore drives its import into the 
nucleus. To test this hypothesis immunoprecipitation experiments with both point mutants 
and the wild type (WT) TERT were performed (figure 15), but no reduced binding of importin-
7 compared to WT TERT could be detected in the mutants. This would be expected when 
importin-7 binds the identified NLS motifs. 
In contrast, it is known that importin-7 mostly binds long stretches of amino acids within its 
substrate. EZI for example is bound by importin-7 at several of its zinc-finger regions over a 
stretch of 52 amino acids and no distinct NLS motif could have been found within this protein 
(Saijou et al., 2007). Other importin-7 substrates are also bound by importin-7 via long 
stretches of amino acids. In the case of the histone protein H1, for example, the whole 





protein seems to be involved in its import (Bäuerle et al., 2002). The binding region in HIV-
integrase, which is also imported by importin-7, consists of 76 amino acids stretching from 
amino acids 212-288. Interestingly, this protein is also imported by many other import 
receptors (reviewed in Chook et al., 2011). Considering the results in other importin-7 
substrates it is possible that TERT also uses long stretches of amino acids that serve as an 
importin-7 docking site. It could be that importin-7 binds great parts of the TERT protein. The 
identified motifs could then act as initial docking sites for importin-7 binding while other 
regions of the protein also contribute to import.  
On the other hand, due to the known problem of insolubility of TERT during recombinant 
expression in E.coli, we were never able to show a direct interaction of TERT or TERT-NLS 
mutants with importin-7. In a cell lysate, barriers that separate the organelles such as the 
nuclear membrane which separates the nucleus from the cytoplasm no longer exist, allowing 
proteins to have contact with each other that would not occur under native cellular 
conditions. It could therefore be that TERT interacting proteins which might also be bound 
and imported by importin-7 now have access also to the NLS mutated TERTs because they use 
a different binding region on the protein than the import receptor. This could lead to an 
indirect importin-7 binding of the NLS-mutated TERT proteins. 
However, overexpressed GFP-TERT CT (aa 601-1132) and GFP TERT NT (aa 1-600) both 
showed a reduced nuclear localization after knock down of importin-7, suggesting a role of 
importin-7 in nuclear import of both truncation mutants (figure S 10). Under mock conditions 
localization of these TERT truncation mutants is predominant nuclear (figure S 10). 
 
 
The influence of Nup358 on TERT import 
The data from this work and previous work (Hutten 2007) show a dependency of TERT import 
on the nucleoporin Nup358. The question arose whether a specific region in Nup358 is 
required for an efficient transport of TERT or whether only the full length Nup can mediate 
import of TERT. It was already known from previous studies that Nup358 is required for the 
import of a certain subset of proteins, for example DBC-1 or HIV-1 Rev (Waelde 2010; Hutten 
et al., 2009). For DBC-1, a Nup region containing aa 1-1170 (ending in front of Ran-binding 
domain1 (RB1) including 3 FG-repeats) was described as the region responsible for its import 





(Wälde et al., 2012). In contrast to these findings, TERT import depends on a region further 
downstream (aa 1-1810) containing the zinc-fingers region of Nup358.  
A region in TERT responsible for Nup358 dependency could not be defined, since TERT 
fragments always localized to the nucleus after depletion of Nup358 (data not shown). The 
dependency of TERT on the nucleoporin could only be shown for the full length TERT. 
It can be concluded that there is no general region or motif in Nup358 specifically responsible 
for the import of the group of Nup358 dependent proteins. Furthermore, proteins seem to 
require different and very defined and independent regions on the Nup for their import. It 
was suggested that Nup358 provides a platform for substrate binding prior to their import 
(Wälde et a., 2012; Pante et al., 1993).  
TERT nuclear import is dependent on the presence of both, importin-7 and Nup358. It was 
therefore interesting to investigate whether importin-7 mediated protein import in general 
depends on the presence of the nucleoporin. EZI was shown to be specifically imported by 
importin-7 (Saijou et al., 2007). In Nup358 depleted cells EZI still localized to the nucleus, 
suggesting that importin-7 mediated import in general is not affected by Nup358 depletion 
and therefore not dependent on Nup358. It is therefore TERT itself that is dependent on 
Nup358, supporting the already mentioned theory that Nup358 provides an assembly 
platform for certain substrates. Proteins may therefore interact with different parts of 
Nup358 to be correctly assembled with their import receptor. 
The finding that importin-7 mediated import of proteins does not generally depend on 
Nup358 might be also supported by the finding that importin-7 does not interact with 
Nup358 without RanGTP as a cofactor (figure 18). It might not interact strongly with the Nups 
FG repeats. Also, the observed binding of importin-7 to Nup358 mediated by RanGTP seems 
to be weak under the immunoprecipitation conditions (figure 18 A), although RanGTP- 
mediated binding of importin-7 to Nup358 fragments was stronger in vitro (figure 18 B). Ran 
dependant binding of importin-7 to a nucleoporin rather supports the suggestion that 











Inhibition of TERT import can be enhanced by co-depletion of importin-7 and Nup358 
One could argue that the cytoplasmic localization of TERT after Nup358 depletion could also 
result from enhanced or accelerated export of the protein instead of impaired import. It was 
already shown, in previous work that depletion of Nup358 does not lead to accelerated 
export of the affected proteins (Wälde 2010). FLIP experiments also showed an impaired 
import after depletion of importin-7. Considering these data, it seems likely that in this case 
also depletion of Nup358 results in an impaired import of TERT. 
The detailed mechanism of Nup358 responsibility in import of TERT still remains unclear. It is 
also unclear whether Nup358 binds to TERT and if yes, whether other proteins are also 
involved in assembly. It also remains unclear where importin-7 binding to TERT occurs and 
whether it is affected by Nup358. 
From these findings the question arises why transport of certain proteins depend on the 
presence of single Nups? It will need further investigation to discover the molecular 
mechanisms behind this specific behavior. 
The model shown below (figure 21) describes a putative mechanism of nuclear import of 
TERT by importin-7 and Nup358. TERT could use the zinc finger region of Nup358 as a 
platform prior to its import. Importin-7 could bind the telomerase protein there and deliveres 
it into the nucleus. RanGTP and TERT interacting factors could help to disolve the importin-
substrate complex in the nucleus. The newly formed importin-7-RanGTP complex could then 
leave the nucleus again by binding to nucleoporins e.g. Nup358, to be recycled back to the 









































Figure 21: Model of TERT recognition by importin-7 and later dissociation of the complex 
TERT could be recruited to Nup358, which provides a platform for proteins prior to their import. TERT can be 
there recognized and bound to importin-7 which transports it through the pore into the nucleus. Once in the 
nucleus, RanGTP together with other TERT interacting factors triggers the dissociation of the import complex. 
The importin-7- RanGTP complex leaves the nucleus by interaction of RanGTP with nucleoporins (e.g. Nup358). 
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Within the course of this study the import of overexpressed human TERT into the nucleus was 
examined. We found the import receptor importin-7 to be essential for TERT nuclear import. 
The filamentous nucleoporin Nup358 also plays a role in import of TERT. First of all, the 
binding of TERT to importin-7 has to be further investigated. Although, we found NLS motifs 
within the protein sequence which strongly influenced its localization it remained unclear 
whether importin-7 directly binds these motifs. To answer this question, the big problem of 
recombinant expression of TERT in E.coli or in insect cells first has to be solved. With 
recombinantly expressed TERT, many problems hindering this work could be solved. The 
interaction between importin-7 and TERT could be further investigated. It can be 
distinguished whether it is a direct interaction or mediated by binding of secondary proteins. 
A putative role of the TERT RNA component in nuclear import or in disassembly of the 
receptor-substrate complex in the nucleus could be investigated. Import assays provide an 
option to investigate import pathways of proteins and still provide the barrier of the nuclear 
membrane combined with selective transport of proteins through the pore. These assays 
could then be performed to gain further insights into TERT nuclear import. Also the RanGTP 
dependant disassembly of TERT-importin-7 complex in the nucleus can be further 
investigated using purified proteins. Furthermore, the ability of importin-7 to bind to NLS 
mutated TERTs could be observed without the influence of other proteins derived from a cell 
lysate. 
It would also be interesting to see whether endogenous TERT responds in a similarly manner 
to overexpressed TERT towards an importin-7 knock-down. For this, a specific antibody 
against human TERT is required, combined with cells expressing rather high levels of 
endogenous TERT.  
The influence of Nup358 on TERT nuclear import could also benefit from the availability of 
recombinant TERT and a TERT specific antibody. The specific role of the zinc finger region of 
Nup358 on TERT nuclear import, can be further investigated using binding assays or with 
immunofluorescence. 
Taken together, these approaches could contribute to gain further insights into the precise 


















S1: Concentration dependency approach of 15d-PGJ2 
HeLa p4 cells were grown on coverslides. Prior to incubation with biotinylated 15d-PGJ2 medium was 
changed to 400µl serum free medium per 24-well. Cells were incubated with either 5µM, 10µM or 
15µM of biotinylated 15d-PGJ2 for 15 minutes to test the ability of 15d-PGJ2 to be imported into the 
nucleus. Biotin was visualized after fixation by using Streptavidin coupled to a fluorophore with an 
excitation at 488nm. Images were taken by using the reuse function to retain the same settings 
throughout the experiment. As shown in the images already lower concentrations of 15d-PGJ2 e.g. 
5µM are detectable in the nucleus after 15 minutes of incubation. The amount of detectable 15d-






S2: Inhibition of TERT import after importin-7 depletion with siRNA importin-7-1 
A second siRNA against importin-7 was tested. The siRNA importin-7-1 was purchased to validate the 


































S3: Live cell imaging using FLIP showing no inhibition of import after 15d-PGJ2 application 
HeLa p4 cells were transiently transfected with the artificial import substrate NES-GFP2-M9. The M9 
sequence is recognized by the import receptor transportin, in contrast, CRM1 recognized the NES 
motif. Prior to FLIP analysis cells were incubated with either 15µM of 15d-PGJ2 or Ethanol as a 
solvent control, for 1 hour in serum-free medium. Cell medium was later changed to CO2- 
independent medium and FLIP was carried out in a preheated microscope chamber at 37°C. As 
shown in the diagram, import in the analyzed cells was not affected by application of 15d-PGJ2. For 

















S4: Localization of TERT N-terminal truncation mutants  



















Import of NES-GFP2-M9 
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S5: Mutation of the NLS-motif in TERT N-terminus  
GFP-TERT N-terminus (GFP-TERT NT) contained the NLS-motif at position 236-240 and localized to 
the nucleus exclusively. Mutation of the last 2 arginines (239/240) to alanines did not change 
localization of the TERT truncation mutant GFP-TERT NT 239 RR-AA indicating that the last 2 residues 
are not essential for its import. Mutation of the full NLS-site (GFP-TERT NT 236-240 AAPAA) indeed 
changed localization of the construct. More than 25% of the analyzed cells showed an equal 
localization of this TERT N-terminal mutant between nucleus and cytoplasm. This gave the first hints 

















































(sec) Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 Cell 6 Cell 7 Cell 8 Cell 9 Cell 10 
0 840,2 990,9 1537,9 910,6 1734,5 925,4 970,6 1697 1205,2 1374,9 
0,154 825,5 979,8 1554,8 897,7 1736,3 928,2 974 1688,7 1218,9 1360,5 
0,309 814,2 964,7 1529,1 884,4 1697,7 917,4 953,3 1691,7 1176,2 1382,2 
0,463 806,9 970,2 1514,5 868,2 1680,6 908,5 966,2 1675,9 1173,8 1368 
 


















S6: Raw FLIP data from the first 10 FLIPs of Roi2 from each mutant 
The tables show the raw FLIP data of the first five fluorescence intensities taken in a FLIP 
measurement. They show the fluorescence measured in pixels of Roi2 (region of interest2) from the 
first 10 FLIPs performed in each mutant. These pixel intensities show that the initial fluorescence in 
the cytoplasm of the analyzed cells was comparable.  
The picture below the tables shows a typical example of the localization of the different Rois used in 
the FLIP measurements. Roi1 marks the bleaching region of the analyzed cell, while Roi2 is the region 
in the cytoplasm where loss of fluorescence is measured. Roi3 indicates a comparable region to Roi2 
in the reference cell. In Roi4 the background of the measurement is taken. 
 
time 
(sec) Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 Cell 6 Cell 7 Cell 8 Cell 9 Cell 10 
0 1005,4 780 1463,6 917,8 1294,8 1181 1084,5 1187,3 964,2 1216,6 
0,154 992,7 755 1422,2 886,1 1273,4 1174,4 1061,9 1179,4 952 1200,2 
0,309 981,4 764,9 1424,3 902,5 1276,9 1164,5 1058 1187,8 944,2 1185,6 
  0,463 962,6 760,2 1412,2 870,8 1258,9 1151,4 1036,7 1202,6 934,5 1193,9 
time 
(sec) Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 Cell 6 Cell 7 Cell 8 Cell 9 Cell10 
0 1372,1 1014,3 1095,2 1222,8 1142,4 1331 1297,5 916,9 1007,3 988 
0,154 1342,5 993,1 1081,5 1191,2 1131,7 1324,8 1297,8 923,6 978,4 988,2 
0,309 1324,2 985,1 1094,9 1172,7 1126,6 1319,9 1280,4 931,2 983,5 970,2 
0,463 1321,8 982,1 1093 1190,2 1103,2 1302,4 1277,4 906,6 984,6 967,8 












S7: FLIP analysis of TERT-GFP export +/- LMB 
Human TERT is exported by CRM1 (Seimiya et al., 2000). To illustrate and to compare transport 
kinetics of TERT-GFP in general TERT-GFP export was analyzed by FLIP. To measure Crm1 mediated 
export of TERT-GFP, cells were either treated with 5nM of the specific Crm1 inhibitor LMB for 2 hours 
prior to FLIP analysis or were left untreated (mock). To guarantee viability of cells throughout the 
whole measurement CO2 independent medium was used during analysis.  







(sec) Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 Cell 6 Cell 7 Cell 8 Cell 9 Cell 10 
0 1069,3 1404,6 882,5 1166,7 1080,2 998,5 1021,6 1191,6 852,3 1181,6 
0,154 1041,6 1395,3 870,2 1141,9 1091,9 982,5 1030,6 1195,6 864,7 1176,1 
0,309 1030,6 1375,2 849,5 1135,5 1069,1 970,5 1016,9 1155,7 847,1 1147,6 




(sec) Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 Cell 6 Cell 7 Cell 8 Cell 9 Cell 10 
0 969,1 753,1 707,2 1035,4 1003,8 939,3 1346,5 1006,9 1005,2 996,2 
0,154 929 728,1 683,2 1035,1 1003,2 911,2 1344 983,3 995,8 964,8 
0,309 931 728,4 675,6 1006,9 986,7 925,1 1362,7 985,4 963 967,5 
0,463 926,9 718,3 674,5 1005 982 885,4 1321,6 991,4 959,2 972,9 
 
S8: Raw FLIP data of TERT-GFP from the first 10 FLIPs of Roi2 after knock down of importin-7 or 
mock  
The tables show the raw FLIP data of the first 5 pictures taken in a FLIP measurement. They show the 
fluorescence measured in pixels of Roi2 (region of interest2) from the first 10 FLIPs performed in 
both conditions. These pixel data show that the starting fluorescences in the cytoplasm (Roi2) of the 


















Export of TERT-GFP 
TERT LMB
TERT Mock
TERT-GFP  mock (non-targeting siRNA) 





























S9: Importin-7 did not dissociate from TERT-GFP by addition of GTP loaded RanQ69L 
293T cells were transiently transfected with either TERT-GFP (TERT) or an empty GFP-vector as a 
control. After immunoprecipitation(IP) using the GFP nanotrap the IP was washed and divided into 4 
samples. The first sample was left untreated (TERT-GFP) showing the endogenous bound importin-7. 
To the three remaining IP samples different concentrations of previous GTP loaded RanQ69L (QL) 
were added and incubated on the beads for 30 minutes, at 4°C with rotation followed by washing 
with GFP- dilution buffer. Even the application of high levels of RanGTP (10µg) was not sufficient to 
reduce the amount of endogenous Importin7 bound to TERT-GFP. Only a very slight reduction of 


























































































Figure S10: Comparison of TERT truncation constructs and the NT-import defective mutant in Mock 
and importin-7 knock-down conditions. 
Full length TERT-GFP shows the characteristic import defect after importin-7 depletion. The WT 
TERT-NT truncation mutant also shows a reduced nuclear localization, indicating that importin-7 is 
involved in its import.  
Under mock conditions the N-terminal NLS mutant GFP-TERT NT KRPRR 236-240 AAPAA already 
shows a reduced nuclear localization which was enhanced under knock-down conditions. 
The TERT CT construct (aa601-1132) also responded to the knock-down of importin-7, suggesting 
another binding site for importin-7. 
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Figure S11: Original FLIP data with standard deviation of TERT-NLS mutants  







Figure S12: Original FLIP data with standard deviation of TERT-GFP 
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°C    degree celsius 
g    gram 
x g    acceleration of gravity on earth 
h    hour(s) 
l    liter 
M    molar (mol/l) 
min    minute(s) 
m    meter 
OD    optical density 
pH    potential hydrogen 
rpm    rotations per minute 
s    second(s) 
U    Unit 




k    kilo-    103 
c    centi-    10-2 
m   mili-    10-3 
μ    micro-    10-6 
n    nano-    10-9 











Code for amino acids 
 
A    Ala    alanine 
C    Cys    cysteine 
D   Asp    aspartate 
E    Glu    glutamate 
F    Phe    phenylalanine 
G    Gly    glycine 
H    His    histidine 
I    Iso    isoleucine 
K    Lys    lysine 
L    Leu    leucine 
M    Met    methionine 
N    Asn    asparagine 
P    Pro    proline 
Q    Gln    glutamine 
R    Arg    arginine 
S    Ser    serine 
T    Thr    threonine 
V    Val    valine 
W    Trp    tryptophane 
Y    Tyr    tyrosine  
X   any 




15d-PGJ2  15-deoxy- 
Δ12,14 prostaglandinJ2 
A    adenine (DNA and RNA) 
Aa    amino acids 






ATP    adenosine-5-triphosphate 
BIB    beta-like import receptor binding 
bp    basepair 
BSA    bovine serum albumine 
C    cytosine (DNA and RNA) 
CRM1    chromosome region maintenance 1 
C-terminus   carboxy terminus 
Da   Dalton 
DBC-1   depleted-in-breast-cancer-1 
DMEM   Dulbeccos’s modified eagles medium 
DMSO    dimethyl sulfoxide 
DNA    desoxyribonucleic acid 
dNTP    2’-desoxynucleoside-5’-triphosphate 
DTT    dithiothreitol 
ECL    enhanced chemical luminescence 
E. coli    Escherichia coli 
EDTA    ethylenediaminetetraacetic acid 
ETOH    ethanol 
FCS    fetal calf serum 
FG-repeat   phenylalanine glycine repeat 
FLIP    fluorescence loss in photo bleaching 
G    guanine (DNA and RNA) 
GAP    GTPase-activating protein  
GDP    guanosine-5’-diphosphate 
GFP    green fluorescent protein 
GST    glutathione-S-transferase 
GTP    guanosine-5’-triphosphate 
GTPase   GTP-hydrolase 
HA    hemagglutinin 






HEAT  Huntington, elongation factor 3, ‘A’ subunit of protein phosphatase 2A 
and TOR1 
HEPES   [4-(2-hydroxyethyl)-1-piperazine]ethanesulfonic 
His    histidine tag 
HIV    human immunodeficiency virus 
IF    immunofluorescence 
Imp/ IPO  importin 
IP    immunoprecipitation 
IPTG    isopropyl-β-D-thiogalactopyranoside 
KD   knock-down 
LB    Luria-Bertani 
LMB    leptomycin B 
NC2β   negative-cofactor-2-β 
NES    nuclear export signal 
cNLS    (classical) nuclear localization signal 
NP40    octyl phenoxylpolyethoxylethanol 
NPC    nuclear pore complex 
NTE   N-terminal extension 
N-terminus   amino terminus 
Nup    nucleoporin 
PAGE    polyacrylamide gel electrophoresis 
PBS    phosphate buffered saline 
PCR    polymerase chain reaction 
PG   prostaglandin 
POM    pore membrane protein 
PY-NLS   proline tyrosine-NLS, motif for interaction of transportin 
pH    negative common logarithm of the proton 
PMSF    phenylmethylsulphonyl fluoride 
Ran    Ras related nuclear protein 
RanBP1   Ran binding protein 1 






RanBD   Ran binding domain 
RCC1    regulator of chromosome condensation 1 
RFP   red fluorescent protein 
RID1    RNA interaction domain1 
RNA    ribonucleic acid 
ROI    region of interest 
RNAi    RNA interference 
RNase    ribonuclease 
RT   reverse transcriptase 
SDS    sodium dodecyl sulfate 
siRNA    small interfering RNA 
T    thymine, in context of DNA and RNA 
TAE    Tris / Acetate / EDTA 
TAP Tip-(Herpesvirus saimiri tyrosine-kinaseinteracting-protein) associated 
protein 
TE    Tris / EDTA 
TERT   telomerase reerse transcriptase (protein subunit) 
TFIIAα   transcription-factor-II-α 
TR   telomerse RNA 
TRBD   telomerase RNA binding domain 
Triton X-100   4-octylphenol polyethoxylate 
Tween20   polyoxyethylene (20) sorbitan monolaurate 
U    uracile, in context of RNA 
UV    ultraviolet 
v/v    volume per volume  
WB    western blot 
wt    wild type 
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